Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-128-3p ABL1 0.98 6.0E-5 -0.96 0 MirTarget -0.16 0.00096 NA
2 hsa-miR-141-3p ABL1 1.46 0.00116 -0.96 0 MirTarget -0.19 0 NA
3 hsa-miR-142-5p ABL1 1.56 1.0E-5 -0.96 0 MirTarget -0.17 0 NA
4 hsa-miR-15b-3p ABL1 1.76 0 -0.96 0 MirTarget -0.15 4.0E-5 NA
5 hsa-miR-15b-5p ABL1 1.62 0 -0.96 0 mirMAP -0.2 0 NA
6 hsa-miR-16-5p ABL1 1.01 1.0E-5 -0.96 0 mirMAP -0.28 0 NA
7 hsa-miR-19a-3p ABL1 1.27 0.00011 -0.96 0 mirMAP -0.16 2.0E-5 NA
8 hsa-miR-200a-3p ABL1 0.72 0.19391 -0.96 0 MirTarget -0.12 0 NA
9 hsa-miR-29a-5p ABL1 0.59 0.02301 -0.96 0 MirTarget -0.13 0.00827 NA
10 hsa-miR-30b-5p ABL1 -0.43 0.05936 -0.96 0 MirTarget; miRNATAP -0.14 0.0083 NA
11 hsa-miR-30e-5p ABL1 -0.57 0.01125 -0.96 0 MirTarget; miRNATAP -0.15 0.00794 NA
12 hsa-miR-330-5p ABL1 0.49 0.05122 -0.96 0 MirTarget -0.24 0 NA
13 hsa-miR-423-5p ABL1 0.83 0.00079 -0.96 0 MirTarget -0.15 0.00245 NA
14 hsa-miR-484 ABL1 0.71 0.00234 -0.96 0 miRNAWalker2 validate -0.26 0 NA
15 hsa-miR-503-5p ABL1 1.89 0 -0.96 0 mirMAP -0.1 0.00051 NA
16 hsa-let-7d-5p ABL2 0.98 0 0.26 0.18922 miRNATAP -0.22 0.00166 NA
17 hsa-let-7g-3p ABL2 0.65 0.01031 0.26 0.18922 mirMAP -0.19 0.00045 NA
18 hsa-let-7g-5p ABL2 0.33 0.24114 0.26 0.18922 miRNATAP -0.15 0.00245 NA
19 hsa-miR-106b-5p ABL2 1.71 0 0.26 0.18922 MirTarget -0.18 5.0E-5 NA
20 hsa-miR-107 ABL2 0.9 5.0E-5 0.26 0.18922 MirTarget; PITA; miRanda; miRNATAP -0.28 0 NA
21 hsa-miR-126-5p ABL2 0.42 0.07532 0.26 0.18922 mirMAP -0.18 0.00191 NA
22 hsa-miR-1266-5p ABL2 0.21 0.74156 0.26 0.18922 MirTarget -0.12 0 NA
23 hsa-miR-128-3p ABL2 0.98 6.0E-5 0.26 0.18922 MirTarget -0.19 0.00069 NA
24 hsa-miR-140-3p ABL2 -0.3 0.12754 0.26 0.18922 miRNAWalker2 validate -0.24 0.00119 NA
25 hsa-miR-148a-5p ABL2 -0.69 0.0793 0.26 0.18922 miRNATAP -0.19 0 NA
26 hsa-miR-15b-5p ABL2 1.62 0 0.26 0.18922 MirTarget; miRNATAP -0.13 0.00819 NA
27 hsa-miR-16-5p ABL2 1.01 1.0E-5 0.26 0.18922 miRNAWalker2 validate; MirTarget; miRNATAP -0.2 0.00107 NA
28 hsa-miR-17-3p ABL2 1.31 0 0.26 0.18922 mirMAP -0.22 2.0E-5 NA
29 hsa-miR-186-5p ABL2 0.15 0.43471 0.26 0.18922 MirTarget; mirMAP -0.22 0.00329 NA
30 hsa-miR-188-5p ABL2 1.35 0.00038 0.26 0.18922 mirMAP -0.15 3.0E-5 NA
31 hsa-miR-200a-5p ABL2 1.5 0.00264 0.26 0.18922 mirMAP -0.12 0 NA
32 hsa-miR-200b-3p ABL2 0.97 0.0595 0.26 0.18922 MirTarget -0.13 0 NA
33 hsa-miR-200b-5p ABL2 0.97 0.05305 0.26 0.18922 mirMAP -0.16 0 NA
34 hsa-miR-200c-3p ABL2 1.28 0.0037 0.26 0.18922 MirTarget -0.13 4.0E-5 NA
35 hsa-miR-26a-5p ABL2 -0.38 0.04425 0.26 0.18922 MirTarget; miRNATAP -0.31 3.0E-5 NA
36 hsa-miR-26b-5p ABL2 -0.3 0.16008 0.26 0.18922 MirTarget; miRNATAP -0.33 0 NA
37 hsa-miR-29a-3p ABL2 -0.11 0.61501 0.26 0.18922 mirMAP -0.25 5.0E-5 NA
38 hsa-miR-29c-3p ABL2 -1.62 0 0.26 0.18922 mirMAP -0.13 0.00169 NA
39 hsa-miR-30b-5p ABL2 -0.43 0.05936 0.26 0.18922 mirMAP -0.21 0.00063 NA
40 hsa-miR-30d-3p ABL2 -0.55 0.04337 0.26 0.18922 mirMAP -0.16 0.00253 NA
41 hsa-miR-30d-5p ABL2 -0.55 0.01401 0.26 0.18922 mirMAP; miRNATAP -0.23 0.00018 NA
42 hsa-miR-30e-3p ABL2 -0.91 1.0E-5 0.26 0.18922 mirMAP -0.25 0.00019 NA
43 hsa-miR-335-5p ABL2 1.6 6.0E-5 0.26 0.18922 mirMAP -0.17 0 NA
44 hsa-miR-33a-3p ABL2 0.35 0.32171 0.26 0.18922 mirMAP -0.15 0.00026 NA
45 hsa-miR-378a-3p ABL2 -0.19 0.5308 0.26 0.18922 mirMAP -0.21 0 NA
46 hsa-miR-378c ABL2 -1.28 3.0E-5 0.26 0.18922 mirMAP -0.25 0 NA
47 hsa-miR-429 ABL2 1.4 0.009 0.26 0.18922 MirTarget -0.13 0 NA
48 hsa-miR-500a-5p ABL2 0 0.99212 0.26 0.18922 mirMAP -0.11 0.00636 NA
49 hsa-miR-589-5p ABL2 0.7 0.00396 0.26 0.18922 MirTarget; miRNATAP -0.15 0.00782 NA
50 hsa-miR-590-3p ABL2 1.12 0.00016 0.26 0.18922 PITA; mirMAP; miRNATAP -0.13 0.00684 NA
51 hsa-miR-625-3p ABL2 -0.19 0.62622 0.26 0.18922 mirMAP -0.18 0 NA
52 hsa-miR-7-1-3p ABL2 0.71 0.04123 0.26 0.18922 mirMAP -0.14 0.00033 NA
53 hsa-miR-21-5p AKT2 1.75 0 -0.01 0.9227 miRNAWalker2 validate -0.15 0.00352 NA
54 hsa-miR-29b-3p AKT2 -0.23 0.36746 -0.01 0.9227 MirTarget -0.14 0.00022 26512921; 26564501; 24076586 MicroRNA 29B mir 29b regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3;The expression of miR-29b was significantly upregualted by cisplatin treatmentwhile its target gene AKT2 was downregulated;Furthermore a feed-back loop comprising of c-Myc miR-29 family and Akt2 were found in myeloid leukemogenesis
55 hsa-miR-106b-5p AKT3 1.71 0 -0.75 0.06936 miRNATAP -0.37 7.0E-5 NA
56 hsa-miR-107 AKT3 0.9 5.0E-5 -0.75 0.06936 PITA; miRanda -0.6 0 NA
57 hsa-miR-15b-5p AKT3 1.62 0 -0.75 0.06936 miRNATAP -0.36 0.00041 NA
58 hsa-miR-16-5p AKT3 1.01 1.0E-5 -0.75 0.06936 miRNAWalker2 validate; miRTarBase; miRNATAP -0.47 0.00031 NA
59 hsa-miR-17-3p AKT3 1.31 0 -0.75 0.06936 miRNATAP -0.52 0 NA
60 hsa-miR-17-5p AKT3 1.66 0 -0.75 0.06936 TargetScan; miRNATAP -0.28 0.0027 NA
61 hsa-miR-29a-3p AKT3 -0.11 0.61501 -0.75 0.06936 miRNATAP -0.41 0.00212 NA
62 hsa-miR-29b-3p AKT3 -0.23 0.36746 -0.75 0.06936 miRNATAP -0.34 0.00361 26512921 MicroRNA 29B mir 29b regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3
63 hsa-miR-32-3p AKT3 0.58 0.11837 -0.75 0.06936 mirMAP -0.32 0.00023 NA
64 hsa-miR-320b AKT3 1.11 0.0005 -0.75 0.06936 PITA; miRanda; miRNATAP -0.26 0.0039 NA
65 hsa-miR-335-3p AKT3 2.52 0 -0.75 0.06936 mirMAP -0.22 0.00074 NA
66 hsa-miR-33a-3p AKT3 0.35 0.32171 -0.75 0.06936 mirMAP -0.38 2.0E-5 NA
67 hsa-miR-362-3p AKT3 -0.03 0.91378 -0.75 0.06936 miRanda -0.38 4.0E-5 NA
68 hsa-miR-362-5p AKT3 -0.35 0.35491 -0.75 0.06936 PITA; TargetScan; miRNATAP -0.23 0.00253 NA
69 hsa-miR-501-3p AKT3 0.73 0.02704 -0.75 0.06936 miRNATAP -0.39 1.0E-5 NA
70 hsa-miR-502-3p AKT3 -0.16 0.55747 -0.75 0.06936 miRNATAP -0.5 0 NA
71 hsa-miR-505-3p AKT3 0.83 0.00112 -0.75 0.06936 mirMAP -0.35 0.00235 22051041 We also find that Akt3 correlate inversely with miR-505 modulates drug sensitivity in MCF7-ADR
72 hsa-miR-548v AKT3 -0.16 0.70867 -0.75 0.06936 miRNATAP -0.27 0.00031 NA
73 hsa-miR-577 AKT3 0.91 0.22561 -0.75 0.06936 mirMAP -0.23 0 NA
74 hsa-miR-616-5p AKT3 0.83 0.03478 -0.75 0.06936 mirMAP -0.27 0.00041 NA
75 hsa-miR-429 ANGPT1 1.4 0.009 -0.53 0.28334 miRanda -0.3 0 NA
76 hsa-miR-129-5p ANGPT2 -2.57 0 1.7 0 MirTarget; miRanda -0.13 0.00318 NA
77 hsa-miR-145-5p ANGPT2 -1.75 2.0E-5 1.7 0 MirTarget; miRNATAP -0.22 0.00012 24384875; 27570490 miR 145 functions as tumor suppressor and targets two oncogenes ANGPT2 and NEDD9 in renal cell carcinoma; We further validated those miR-145 targets two oncogenes ANGPT2 and NEDD9 in RCC;MiR 145 functions as a tumor suppressor via regulating angiopoietin 2 in pancreatic cancer cells; The direct action of miR-145 on Ang-2 was predicted by TargetScan and confirmed by luciferase report assay; The expression level of miR-145 was significantly lower and the expression levels of Ang-2 mRNA and protein was significantly higher in the more aggressive pancreatic cancer cells MiaPaCa-2 and Panc-1 when compared to that in BxPC3 cells; Overexpression of miR-145 in the BxPC3 MiaPaCa-2 and Panc-1 cells suppressed the cell invasion and colony formation ability and the expression level of Ang-2 protein in MiaPaCa-2 and Panc-1 cells was also suppressed after pre-miR-145 transfection; Intratumoral delivery of miR-145 inhibited the growth of pancreatic cancer xenografts and angiogenesis in vivo and also suppressed the expression level of angiopoietin-2 protein; MiR-145 functions as a tumor suppressor in pancreatic cancer cells by targeting Ang-2 for translation repression and thus suppresses pancreatic cancer cell invasion and growth which suggests that restoring of miR-145 may be a potential therapeutic target for pancreatic cancer
78 hsa-miR-664a-3p ANGPT2 -0.83 0.00014 1.7 0 mirMAP -0.37 0.00076 NA
79 hsa-miR-10a-3p ARF6 0.22 0.56058 0.25 0.18203 miRNATAP -0.11 0.00124 NA
80 hsa-miR-181c-5p ARF6 0.34 0.11293 0.25 0.18203 MirTarget -0.18 0.00393 NA
81 hsa-miR-181d-5p ARF6 0.65 0.01434 0.25 0.18203 MirTarget -0.16 0.00106 NA
82 hsa-miR-217 ARF6 -0.01 0.98082 0.25 0.18203 miRanda -0.1 6.0E-5 NA
83 hsa-miR-30a-3p ARF6 -1.73 0 0.25 0.18203 MirTarget; miRNATAP -0.14 0.0002 NA
84 hsa-miR-30a-5p ARF6 -1.72 0 0.25 0.18203 miRNAWalker2 validate -0.16 3.0E-5 NA
85 hsa-miR-338-3p ARF6 -0.96 0.01915 0.25 0.18203 miRanda -0.14 1.0E-5 NA
86 hsa-miR-338-5p ARF6 -1.2 0.01003 0.25 0.18203 PITA -0.11 9.0E-5 NA
87 hsa-let-7b-5p BCL2L1 0.06 0.7814 0.21 0.39578 miRNATAP -0.31 0.00027 26915294; 20347499 As a result transcript levels of the tumor-suppressive miR-15 and let-7 families increased which targeted and decreased the expression of the crucial prosurvival genes BCL-2 and BCL-XL respectively;The let 7 family of microRNAs inhibits Bcl xL expression and potentiates sorafenib induced apoptosis in human hepatocellular carcinoma; The effect of let-7 on Bcl-xL expression was examined by Western blot and a reporter assay; Microarray analysis followed by in silico target prediction identified let-7 microRNAs as being downregulated in Huh7 hepatoma cells in comparison with primary human hepatocytes as well as possessing a putative target site in the bcl-xl mRNA
88 hsa-let-7c-5p BCL2L1 -0.5 0.20685 0.21 0.39578 miRNAWalker2 validate; miRTarBase -0.2 1.0E-5 20347499 Over-expression of let-7c or let-7g led to a clear decrease of Bcl-xL expression in Huh7 and HepG2 cell lines; Reporter assays revealed direct post-transcriptional regulation involving let-7c or let-7g and the 3'-untranslated region of bcl-xl mRNA
89 hsa-miR-149-5p BCL2L1 0.71 0.29685 0.21 0.39578 mirMAP -0.17 0 NA
90 hsa-miR-214-3p BCL2L1 1.01 0.00625 0.21 0.39578 mirMAP -0.13 0.00824 NA
91 hsa-miR-23b-3p BCL2L1 -0.29 0.18665 0.21 0.39578 miRNAWalker2 validate -0.39 0 NA
92 hsa-miR-192-3p BDNF 0.36 0.74117 0.74 0.18381 MirTarget; miRNATAP -0.11 0.00424 NA
93 hsa-miR-29b-2-5p BDNF -1.7 0 0.74 0.18381 mirMAP -0.38 0.00762 NA
94 hsa-miR-338-5p BDNF -1.2 0.01003 0.74 0.18381 miRNATAP -0.3 0.00033 NA
95 hsa-let-7i-5p CALM1 0.8 3.0E-5 -0.7 3.0E-5 miRNATAP -0.2 0.00168 NA
96 hsa-miR-142-3p CALM1 1.32 0.00015 -0.7 3.0E-5 miRanda; miRNATAP -0.15 1.0E-5 NA
97 hsa-miR-142-5p CALM1 1.56 1.0E-5 -0.7 3.0E-5 miRNATAP -0.1 0.00342 NA
98 hsa-miR-15a-5p CALM1 1.04 0 -0.7 3.0E-5 miRNATAP -0.17 0.00311 NA
99 hsa-miR-16-2-3p CALM1 1.8 0 -0.7 3.0E-5 mirMAP -0.16 4.0E-5 NA
100 hsa-miR-16-5p CALM1 1.01 1.0E-5 -0.7 3.0E-5 miRNATAP -0.19 0.00043 NA
101 hsa-miR-181a-5p CALM1 1.39 0 -0.7 3.0E-5 miRNATAP -0.25 0 NA
102 hsa-miR-181b-5p CALM1 1.64 0 -0.7 3.0E-5 miRNATAP -0.21 0 NA
103 hsa-miR-181c-5p CALM1 0.34 0.11293 -0.7 3.0E-5 miRNATAP -0.28 0 NA
104 hsa-miR-186-5p CALM1 0.15 0.43471 -0.7 3.0E-5 mirMAP -0.2 0.00218 NA
105 hsa-miR-19a-3p CALM1 1.27 0.00011 -0.7 3.0E-5 miRNATAP -0.13 0.00055 NA
106 hsa-miR-19b-3p CALM1 0.76 0.00653 -0.7 3.0E-5 miRNATAP -0.16 0.00031 NA
107 hsa-miR-335-5p CALM1 1.6 6.0E-5 -0.7 3.0E-5 mirMAP -0.12 6.0E-5 NA
108 hsa-miR-3614-3p CALM1 0.82 0.01436 -0.7 3.0E-5 miRNATAP -0.12 0.0018 NA
109 hsa-miR-423-5p CALM1 0.83 0.00079 -0.7 3.0E-5 miRNATAP -0.13 0.00781 NA
110 hsa-miR-576-5p CALM1 0.63 0.04171 -0.7 3.0E-5 mirMAP -0.13 0.00155 NA
111 hsa-miR-7-1-3p CALM1 0.71 0.04123 -0.7 3.0E-5 mirMAP -0.1 0.00358 NA
112 hsa-let-7a-3p CALM2 0.5 0.04111 0.38 0.00867 miRNATAP -0.11 0.00937 NA
113 hsa-miR-27a-3p CALM3 1.3 0 0.14 0.45436 miRNATAP -0.23 5.0E-5 NA
114 hsa-miR-27b-3p CALM3 0.08 0.72527 0.14 0.45436 miRNAWalker2 validate; miRNATAP -0.23 4.0E-5 NA
115 hsa-miR-34c-5p CALM3 2.21 0.00038 0.14 0.45436 miRanda -0.11 0 NA
116 hsa-miR-411-5p CALML4 0.02 0.95611 0.37 0.32957 MirTarget -0.34 1.0E-5 NA
117 hsa-miR-452-5p CALML4 2.09 0.00026 0.37 0.32957 mirMAP -0.32 0 NA
118 hsa-miR-944 CALML4 3.33 0.01778 0.37 0.32957 PITA; miRNATAP -0.22 0 NA
119 hsa-miR-152-3p CHUK 0.44 0.1617 -0.11 0.43611 MirTarget -0.17 0 NA
120 hsa-miR-195-5p CHUK -0.91 0.00151 -0.11 0.43611 miRNAWalker2 validate; MirTarget -0.13 0.00012 NA
121 hsa-miR-23a-3p CHUK 1.11 0 -0.11 0.43611 MirTarget -0.17 0.00056 NA
122 hsa-miR-23b-3p CHUK -0.29 0.18665 -0.11 0.43611 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.19 6.0E-5 NA
123 hsa-miR-342-3p CHUK 0.32 0.26915 -0.11 0.43611 miRanda -0.19 0 NA
124 hsa-miR-497-5p CHUK -0.8 0.0036 -0.11 0.43611 MirTarget -0.11 0.00273 NA
125 hsa-miR-106a-5p CSF1 -0.17 0.64287 -0.31 0.33962 miRNATAP -0.17 0.00529 NA
126 hsa-miR-128-3p CSF1 0.98 6.0E-5 -0.31 0.33962 MirTarget -0.29 0.00152 22909061 By mutations in putative miRNA targets in CSF-1 mRNA 3'UTR we identified a common target for both miR-128 and miR-152; We have also found that both miR-128 and miR-152 down-regulate CSF-1 mRNA and protein expression in ovarian cancer cells leading to decreased cell motility and adhesion in vitro two major aspects of the metastatic potential of cancer cells; Our results provide the evidence for a mechanism by which miR-128 and miR-152 down-regulate CSF-1 an important regulator of ovarian cancer
127 hsa-miR-130b-3p CSF1 1.33 5.0E-5 -0.31 0.33962 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.25 0.00031 22005523 CSF-1 regulated by miR-130b was detected using Dual Luciferase Reporter system; CSF-1 expression was negatively associated with miR-130b level in ovarian tissues and cell lines; Luciferase assay validated CSF-1 is a direct target of miR-130b; Knock-down of CSF-1 sensitized ovarian cancer cells to anticancer drugs and could partially attenuate the resistance inducing effect of miR-130b inhibitors; Downregulation of miR-130b promotes the development of multidrug resistant ovarian cancer partially by targeting the 3'-UTR of CSF-1 and the silencing of miR-130b may be mediated by DNA methylation
128 hsa-miR-15b-5p CSF1 1.62 0 -0.31 0.33962 miRNATAP -0.24 0.00224 NA
129 hsa-miR-17-5p CSF1 1.66 0 -0.31 0.33962 TargetScan; miRNATAP -0.29 4.0E-5 NA
130 hsa-miR-20a-5p CSF1 1.45 0 -0.31 0.33962 miRNATAP -0.28 0.00019 NA
131 hsa-miR-23b-5p CSF1 0.61 0.04865 -0.31 0.33962 MirTarget -0.26 0.00073 NA
132 hsa-miR-301b-3p CSF1 1.1 0.07156 -0.31 0.33962 MirTarget -0.16 0.00197 NA
133 hsa-miR-429 CSF1 1.4 0.009 -0.31 0.33962 PITA; miRanda; miRNATAP -0.2 0 NA
134 hsa-miR-532-3p CSF1 0.55 0.09755 -0.31 0.33962 MirTarget; PITA -0.18 0.00784 NA
135 hsa-miR-940 CSF1 1.64 0.00069 -0.31 0.33962 MirTarget; PITA; miRNATAP -0.2 0.00032 NA
136 hsa-miR-96-5p CSF1 1.14 0.00943 -0.31 0.33962 miRNATAP -0.26 0 NA
137 hsa-miR-107 CSF1R 0.9 5.0E-5 -1.02 0.01404 miRanda -0.55 4.0E-5 NA
138 hsa-miR-339-5p CSF1R 0.77 0.00817 -1.02 0.01404 miRanda -0.27 0.00729 NA
139 hsa-miR-629-3p CSF1R 1.4 0.0001 -1.02 0.01404 MirTarget -0.23 0.00448 NA
140 hsa-miR-30c-2-3p EFNA1 -1.14 0.00085 1 0.00013 MirTarget -0.2 0.00017 NA
141 hsa-miR-491-5p EFNA1 -0.69 0.03136 1 0.00013 miRanda -0.22 0.00026 NA
142 hsa-miR-205-5p EFNA2 3.14 0.02932 2.57 0.01075 MirTarget -0.39 0 NA
143 hsa-miR-30a-5p EFNA3 -1.72 0 2.03 2.0E-5 MirTarget; mirMAP; miRNATAP -0.58 0 NA
144 hsa-miR-30c-5p EFNA3 -0.98 5.0E-5 2.03 2.0E-5 MirTarget; mirMAP; miRNATAP -0.63 1.0E-5 NA
145 hsa-miR-326 EFNA3 -0.43 0.26299 2.03 2.0E-5 MirTarget; miRanda; miRNATAP -0.31 0.00072 NA
146 hsa-miR-361-3p EFNA3 -0.13 0.56605 2.03 2.0E-5 MirTarget; miRNATAP -0.44 0.00675 NA
147 hsa-miR-140-5p EFNA5 0.21 0.303 -0.59 0.19744 miRanda -0.46 0.00594 NA
148 hsa-miR-186-5p EFNA5 0.15 0.43471 -0.59 0.19744 mirMAP -0.51 0.00337 NA
149 hsa-miR-19a-3p EFNA5 1.27 0.00011 -0.59 0.19744 miRNATAP -0.31 0.00145 NA
150 hsa-miR-19b-3p EFNA5 0.76 0.00653 -0.59 0.19744 miRNATAP -0.3 0.00979 NA
NumGOOverlapSizeP ValueAdj. P Value
1 INTRACELLULAR SIGNAL TRANSDUCTION 106 1572 4.84e-80 2.252e-76
2 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 74 498 3.519e-77 8.187e-74
3 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 74 689 2.248e-66 3.487e-63
4 POSITIVE REGULATION OF MOLECULAR FUNCTION 96 1791 4.515e-61 5.252e-58
5 POSITIVE REGULATION OF CATALYTIC ACTIVITY 89 1518 7.9e-59 6.127e-56
6 PROTEIN PHOSPHORYLATION 76 944 7.528e-59 6.127e-56
7 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 57 404 1.001e-56 6.654e-54
8 PHOSPHORYLATION 79 1228 5.411e-54 3.147e-51
9 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 93 1977 1.38e-53 7.135e-51
10 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 87 1656 3.274e-53 1.524e-50
11 POSITIVE REGULATION OF RESPONSE TO STIMULUS 90 1929 4.393e-51 1.858e-48
12 POSITIVE REGULATION OF KINASE ACTIVITY 54 482 5.33e-48 2.067e-45
13 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 65 876 4.725e-47 1.691e-44
14 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 68 1036 5.667e-46 1.758e-43
15 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 68 1036 5.667e-46 1.758e-43
16 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 69 1135 1.566e-44 4.554e-42
17 REGULATION OF KINASE ACTIVITY 60 776 4.084e-44 1.118e-41
18 POSITIVE REGULATION OF CELL COMMUNICATION 76 1532 2.103e-43 5.436e-41
19 REGULATION OF PHOSPHORUS METABOLIC PROCESS 77 1618 8.861e-43 2.17e-40
20 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 54 616 3.041e-42 7.075e-40
21 REGULATION OF PROTEIN MODIFICATION PROCESS 78 1710 4.209e-42 9.327e-40
22 REGULATION OF MAPK CASCADE 55 660 6.852e-42 1.449e-39
23 POSITIVE REGULATION OF MAPK CASCADE 49 470 9.008e-42 1.822e-39
24 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 72 1492 6.355e-40 1.232e-37
25 REGULATION OF TRANSFERASE ACTIVITY 60 946 3.971e-39 7.392e-37
26 POSITIVE REGULATION OF HYDROLASE ACTIVITY 58 905 5.988e-38 1.072e-35
27 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 31 138 5.443e-37 9.38e-35
28 INOSITOL LIPID MEDIATED SIGNALING 30 124 7.134e-37 1.186e-34
29 REGULATION OF HYDROLASE ACTIVITY 65 1327 6.995e-36 1.122e-33
30 REGULATION OF GTPASE ACTIVITY 50 673 2.031e-35 3.151e-33
31 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 40 352 2.345e-35 3.52e-33
32 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 44 470 2.726e-35 3.964e-33
33 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 37 289 1.316e-34 1.856e-32
34 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 71 1848 7.826e-33 1.071e-30
35 REGULATION OF CELLULAR COMPONENT MOVEMENT 49 771 1.72e-31 2.287e-29
36 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 30 193 1.155e-30 1.493e-28
37 POSITIVE REGULATION OF CELL PROLIFERATION 49 814 2.118e-30 2.664e-28
38 REGULATION OF MAP KINASE ACTIVITY 35 319 2.409e-30 2.95e-28
39 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 34 297 4.183e-30 4.99e-28
40 RAS PROTEIN SIGNAL TRANSDUCTION 27 143 4.778e-30 5.558e-28
41 RESPONSE TO ENDOGENOUS STIMULUS 61 1450 1.001e-29 1.136e-27
42 PHOSPHOLIPID METABOLIC PROCESS 36 364 1.342e-29 1.487e-27
43 GLYCEROLIPID METABOLIC PROCESS 35 356 1.109e-28 1.2e-26
44 POSITIVE REGULATION OF LOCOMOTION 37 420 1.347e-28 1.425e-26
45 ACTIVATION OF PROTEIN KINASE ACTIVITY 32 279 2.311e-28 2.39e-26
46 POSITIVE REGULATION OF MAP KINASE ACTIVITY 29 207 2.705e-28 2.736e-26
47 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 33 323 1.378e-27 1.364e-25
48 REGULATION OF CELL PROLIFERATION 59 1496 3.696e-27 3.582e-25
49 LOCOMOTION 52 1114 4.6e-27 4.368e-25
50 RESPONSE TO GROWTH FACTOR 37 475 1.124e-26 1.046e-24
51 FC RECEPTOR SIGNALING PATHWAY 27 206 1.425e-25 1.3e-23
52 FC EPSILON RECEPTOR SIGNALING PATHWAY 24 142 1.501e-25 1.343e-23
53 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 60 1672 1.694e-25 1.488e-23
54 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 48 1008 3.149e-25 2.713e-23
55 LIPID PHOSPHORYLATION 21 99 1.131e-24 9.569e-23
56 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 17 49 2.803e-24 2.329e-22
57 PEPTIDYL TYROSINE MODIFICATION 25 186 5.294e-24 4.322e-22
58 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 46 1021 3.987e-23 3.198e-21
59 RESPONSE TO EXTERNAL STIMULUS 59 1821 9.346e-23 7.371e-21
60 RESPONSE TO OXYGEN CONTAINING COMPOUND 52 1381 9.851e-23 7.64e-21
61 TAXIS 33 464 1.547e-22 1.18e-20
62 RESPONSE TO NITROGEN COMPOUND 42 859 2.185e-22 1.639e-20
63 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 47 1142 5.251e-22 3.879e-20
64 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 49 1275 1.032e-21 7.503e-20
65 REGULATION OF VASCULATURE DEVELOPMENT 25 233 1.564e-21 1.12e-19
66 REGULATION OF CELL DEATH 52 1472 1.764e-21 1.243e-19
67 GLYCEROLIPID BIOSYNTHETIC PROCESS 24 211 2.621e-21 1.82e-19
68 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 26 278 7.819e-21 5.351e-19
69 REGULATION OF IMMUNE SYSTEM PROCESS 50 1403 9.264e-21 6.247e-19
70 PHOSPHOLIPID BIOSYNTHETIC PROCESS 24 235 3.447e-20 2.292e-18
71 BLOOD VESSEL MORPHOGENESIS 28 364 4.362e-20 2.859e-18
72 NEGATIVE REGULATION OF CELL DEATH 39 872 2.12e-19 1.37e-17
73 CELLULAR RESPONSE TO NITROGEN COMPOUND 31 505 2.539e-19 1.618e-17
74 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 48 1395 2.983e-19 1.876e-17
75 VASCULATURE DEVELOPMENT 30 469 3.273e-19 2.03e-17
76 ORGANOPHOSPHATE METABOLIC PROCESS 39 885 3.543e-19 2.169e-17
77 CELL MOTILITY 38 835 3.744e-19 2.234e-17
78 LOCALIZATION OF CELL 38 835 3.744e-19 2.234e-17
79 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 37 799 6.77e-19 3.987e-17
80 CELL DEVELOPMENT 48 1426 7.328e-19 4.262e-17
81 REGULATION OF ENDOTHELIAL CELL MIGRATION 18 114 7.864e-19 4.408e-17
82 REGULATION OF ERK1 AND ERK2 CASCADE 23 238 7.76e-19 4.408e-17
83 REGULATION OF CELL DIFFERENTIATION 49 1492 7.823e-19 4.408e-17
84 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 21 184 8.819e-19 4.885e-17
85 PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS 18 120 2.051e-18 1.123e-16
86 NEUROGENESIS 47 1402 2.234e-18 1.209e-16
87 CARDIOVASCULAR SYSTEM DEVELOPMENT 36 788 3.394e-18 1.794e-16
88 CIRCULATORY SYSTEM DEVELOPMENT 36 788 3.394e-18 1.794e-16
89 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 20 172 4.288e-18 2.242e-16
90 ANGIOGENESIS 24 293 6.076e-18 3.142e-16
91 REGULATION OF IMMUNE RESPONSE 37 858 7.043e-18 3.601e-16
92 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 37 867 9.9e-18 5.007e-16
93 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 18 133 1.377e-17 6.888e-16
94 LIPID MODIFICATION 21 210 1.393e-17 6.895e-16
95 CELLULAR RESPONSE TO PEPTIDE 23 274 1.825e-17 8.937e-16
96 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 21 213 1.868e-17 9.054e-16
97 PEPTIDYL AMINO ACID MODIFICATION 36 841 2.706e-17 1.298e-15
98 PROTEIN AUTOPHOSPHORYLATION 20 192 3.847e-17 1.827e-15
99 REGULATION OF EPITHELIAL CELL MIGRATION 19 166 4.149e-17 1.95e-15
100 REGULATION OF TRANSPORT 51 1804 6.878e-17 3.2e-15
101 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 13 55 2.393e-16 1.102e-14
102 POSITIVE REGULATION OF CELL DIVISION 17 132 2.69e-16 1.227e-14
103 WOUND HEALING 27 470 3.546e-16 1.602e-14
104 CELLULAR LIPID METABOLIC PROCESS 36 913 3.582e-16 1.603e-14
105 RESPONSE TO WOUNDING 29 563 4.458e-16 1.976e-14
106 ACTIVATION OF MAPK ACTIVITY 17 137 5.103e-16 2.24e-14
107 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 36 926 5.564e-16 2.419e-14
108 REGULATION OF NEURON DEATH 21 252 5.831e-16 2.512e-14
109 CELL PROLIFERATION 31 672 8.055e-16 3.439e-14
110 ERBB SIGNALING PATHWAY 14 79 1.253e-15 5.298e-14
111 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 13 62 1.308e-15 5.482e-14
112 NEURON PROJECTION DEVELOPMENT 28 545 1.629e-15 6.766e-14
113 REGULATION OF PHOSPHOLIPASE ACTIVITY 13 64 2.041e-15 8.403e-14
114 REGULATION OF LIPASE ACTIVITY 14 83 2.593e-15 1.058e-13
115 REGULATION OF CELL PROJECTION ORGANIZATION 28 558 2.953e-15 1.195e-13
116 FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 14 84 3.091e-15 1.24e-13
117 POSITIVE REGULATION OF LIPASE ACTIVITY 13 66 3.135e-15 1.247e-13
118 REGULATION OF CHEMOTAXIS 18 180 3.253e-15 1.283e-13
119 IMMUNE SYSTEM PROCESS 51 1984 3.419e-15 1.337e-13
120 CELL CELL SIGNALING 32 767 4.358e-15 1.69e-13
121 POSITIVE REGULATION OF CELL DIFFERENTIATION 33 823 4.723e-15 1.816e-13
122 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 12 53 6.188e-15 2.36e-13
123 RESPONSE TO HORMONE 34 893 7.709e-15 2.916e-13
124 REGULATION OF CELL ADHESION 29 629 7.938e-15 2.979e-13
125 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 11 40 8.06e-15 3e-13
126 RESPONSE TO PEPTIDE 24 404 8.744e-15 3.229e-13
127 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 17 162 8.829e-15 3.235e-13
128 NEURON DEVELOPMENT 30 687 1.077e-14 3.916e-13
129 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 38 1152 1.46e-14 5.267e-13
130 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 31 750 1.608e-14 5.756e-13
131 CELLULAR RESPONSE TO HORMONE STIMULUS 27 552 1.821e-14 6.468e-13
132 POSITIVE REGULATION OF CHEMOTAXIS 15 120 2.583e-14 9.105e-13
133 REGULATION OF CELL DIVISION 20 272 3.303e-14 1.156e-12
134 TISSUE DEVELOPMENT 43 1518 3.678e-14 1.277e-12
135 CELL PROJECTION ORGANIZATION 33 902 6.329e-14 2.182e-12
136 REGULATION OF LIPID KINASE ACTIVITY 11 48 7.471e-14 2.556e-12
137 LIPID BIOSYNTHETIC PROCESS 26 539 8.117e-14 2.757e-12
138 ORGANOPHOSPHATE BIOSYNTHETIC PROCESS 24 450 9.313e-14 3.14e-12
139 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 12 67 1.268e-13 4.244e-12
140 TUBE DEVELOPMENT 26 552 1.409e-13 4.683e-12
141 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 11 51 1.544e-13 5.094e-12
142 NEURON DIFFERENTIATION 32 874 1.59e-13 5.211e-12
143 ACTIVATION OF IMMUNE RESPONSE 23 427 2.607e-13 8.483e-12
144 REGULATION OF CELL DEVELOPMENT 31 836 2.908e-13 9.396e-12
145 REGULATION OF PHOSPHOLIPASE C ACTIVITY 10 39 3.056e-13 9.741e-12
146 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 10 39 3.056e-13 9.741e-12
147 RESPONSE TO FIBROBLAST GROWTH FACTOR 14 116 3.19e-13 1.01e-11
148 PLATELET ACTIVATION 15 142 3.23e-13 1.016e-11
149 ORGAN MORPHOGENESIS 31 841 3.402e-13 1.062e-11
150 HEMOSTASIS 20 311 4.095e-13 1.27e-11
151 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 12 74 4.428e-13 1.365e-11
152 LIPID METABOLIC PROCESS 36 1158 4.881e-13 1.494e-11
153 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 15 154 1.072e-12 3.259e-11
154 INSULIN RECEPTOR SIGNALING PATHWAY 12 80 1.168e-12 3.53e-11
155 REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 11 61 1.268e-12 3.783e-11
156 REGULATION OF RESPONSE TO STRESS 40 1468 1.263e-12 3.783e-11
157 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 13 103 1.284e-12 3.806e-11
158 REGULATION OF VESICLE MEDIATED TRANSPORT 23 462 1.334e-12 3.929e-11
159 EMBRYO DEVELOPMENT 31 894 1.68e-12 4.916e-11
160 LEUKOCYTE MIGRATION 18 259 1.783e-12 5.184e-11
161 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 32 957 1.819e-12 5.258e-11
162 REGULATION OF NEURON APOPTOTIC PROCESS 16 192 2.058e-12 5.912e-11
163 POSITIVE REGULATION OF CELL DEVELOPMENT 23 472 2.072e-12 5.914e-11
164 EPHRIN RECEPTOR SIGNALING PATHWAY 12 85 2.468e-12 7.003e-11
165 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 19 303 2.568e-12 7.241e-11
166 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 16 195 2.612e-12 7.323e-11
167 RESPONSE TO ORGANIC CYCLIC COMPOUND 31 917 3.24e-12 9.027e-11
168 GLAND DEVELOPMENT 21 395 3.973e-12 1.1e-10
169 NEGATIVE REGULATION OF NEURON DEATH 15 171 4.952e-12 1.363e-10
170 CELL DEATH 32 1001 5.964e-12 1.632e-10
171 HEAD DEVELOPMENT 27 709 6.69e-12 1.821e-10
172 EPITHELIUM DEVELOPMENT 31 945 7.013e-12 1.894e-10
173 REGULATION OF CELLULAR COMPONENT BIOGENESIS 28 767 7.043e-12 1.894e-10
174 REGULATION OF NEURON PROJECTION DEVELOPMENT 21 408 7.334e-12 1.961e-10
175 T CELL RECEPTOR SIGNALING PATHWAY 14 146 7.788e-12 2.071e-10
176 REGULATION OF NEURON DIFFERENTIATION 24 554 7.898e-12 2.088e-10
177 REGULATION OF CELLULAR LOCALIZATION 36 1277 8.386e-12 2.204e-10
178 CELLULAR COMPONENT MORPHOGENESIS 30 900 1.09e-11 2.85e-10
179 POSITIVE REGULATION OF IMMUNE RESPONSE 24 563 1.106e-11 2.876e-10
180 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 18 296 1.671e-11 4.319e-10
181 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 7 17 2.67e-11 6.864e-10
182 CENTRAL NERVOUS SYSTEM DEVELOPMENT 29 872 2.686e-11 6.867e-10
183 POSITIVE REGULATION OF TRANSPORT 30 936 2.872e-11 7.303e-10
184 INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 12 106 3.592e-11 9.085e-10
185 MORPHOGENESIS OF AN EPITHELIUM 20 400 4.05e-11 1.019e-09
186 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 13 135 4.246e-11 1.062e-09
187 REGULATION OF ENDOCYTOSIS 15 199 4.384e-11 1.091e-09
188 NEURON PROJECTION MORPHOGENESIS 20 402 4.427e-11 1.096e-09
189 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 42 1805 4.985e-11 1.227e-09
190 REGULATION OF AXONOGENESIS 14 168 5.239e-11 1.283e-09
191 RESPONSE TO ABIOTIC STIMULUS 31 1024 5.348e-11 1.303e-09
192 REGULATION OF CELL SUBSTRATE ADHESION 14 173 7.768e-11 1.883e-09
193 REGULATION OF EPITHELIAL CELL PROLIFERATION 17 285 8.539e-11 2.059e-09
194 POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 6 11 8.797e-11 2.11e-09
195 POSITIVE REGULATION OF LIPID KINASE ACTIVITY 8 32 9.748e-11 2.326e-09
196 REGULATION OF CELL MATRIX ADHESION 11 90 1.041e-10 2.472e-09
197 CELLULAR RESPONSE TO INSULIN STIMULUS 13 146 1.145e-10 2.704e-09
198 IMMUNE SYSTEM DEVELOPMENT 23 582 1.397e-10 3.283e-09
199 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 18 337 1.407e-10 3.291e-09
200 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 34 1.661e-10 3.864e-09
201 POSITIVE REGULATION OF DNA METABOLIC PROCESS 14 185 1.902e-10 4.403e-09
202 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 20 437 1.945e-10 4.479e-09
203 POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION 7 22 2.267e-10 5.196e-09
204 POSITIVE CHEMOTAXIS 8 36 2.732e-10 6.231e-09
205 REGULATION OF CELL MORPHOGENESIS 22 552 3.119e-10 7.079e-09
206 PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING 7 23 3.237e-10 7.277e-09
207 NEUROTROPHIN SIGNALING PATHWAY 7 23 3.237e-10 7.277e-09
208 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 15 232 3.808e-10 8.519e-09
209 REGULATION OF BODY FLUID LEVELS 21 506 3.944e-10 8.781e-09
210 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 13 162 4.207e-10 9.322e-09
211 CELLULAR RESPONSE TO GLUCAGON STIMULUS 8 38 4.357e-10 9.609e-09
212 REGULATION OF INTRACELLULAR TRANSPORT 23 621 4.96e-10 1.089e-08
213 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 21 513 5.058e-10 1.105e-08
214 ERBB2 SIGNALING PATHWAY 8 39 5.446e-10 1.184e-08
215 TUBE MORPHOGENESIS 17 323 5.916e-10 1.28e-08
216 PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 7 25 6.266e-10 1.35e-08
217 REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 9 59 7.208e-10 1.546e-08
218 RESPONSE TO INSULIN 14 205 7.373e-10 1.574e-08
219 POSITIVE REGULATION OF CELL ADHESION 18 376 8.208e-10 1.744e-08
220 REGULATION OF GLUCOSE IMPORT 9 60 8.424e-10 1.782e-08
221 PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING 7 26 8.519e-10 1.794e-08
222 REGULATION OF DEVELOPMENTAL GROWTH 16 289 9.384e-10 1.967e-08
223 POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 8 42 1.024e-09 2.128e-08
224 POSITIVE REGULATION OF GLUCOSE TRANSPORT 8 42 1.024e-09 2.128e-08
225 REGULATION OF CYTOPLASMIC TRANSPORT 20 481 1.035e-09 2.14e-08
226 POSITIVE REGULATION OF DNA REPLICATION 10 86 1.248e-09 2.569e-08
227 PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING 6 16 1.477e-09 3.027e-08
228 REGULATION OF ORGANELLE ORGANIZATION 31 1178 1.654e-09 3.376e-08
229 CALCIUM MEDIATED SIGNALING 10 90 1.963e-09 3.989e-08
230 REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 6 17 2.268e-09 4.588e-08
231 POSITIVE REGULATION OF AXONOGENESIS 9 69 3.044e-09 6.131e-08
232 CELL ACTIVATION 21 568 3.122e-09 6.262e-08
233 RESPONSE TO GLUCAGON 8 48 3.149e-09 6.289e-08
234 FC GAMMA RECEPTOR SIGNALING PATHWAY 10 95 3.355e-09 6.671e-08
235 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 33 1360 3.415e-09 6.761e-08
236 RESPONSE TO RADIATION 18 413 3.618e-09 7.134e-08
237 CELL PART MORPHOGENESIS 22 633 3.953e-09 7.728e-08
238 REGULATION OF GROWTH 22 633 3.953e-09 7.728e-08
239 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 17 368 4.258e-09 8.29e-08
240 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 11 128 4.736e-09 9.182e-08
241 RESPONSE TO LIGHT STIMULUS 15 280 5.045e-09 9.74e-08
242 REGULATION OF GLUCOSE TRANSPORT 10 100 5.56e-09 1.069e-07
243 TISSUE MORPHOGENESIS 20 533 5.966e-09 1.142e-07
244 MORPHOGENESIS OF A BRANCHING STRUCTURE 12 167 7.141e-09 1.362e-07
245 NEURON PROJECTION GUIDANCE 13 205 7.504e-09 1.425e-07
246 RHYTHMIC PROCESS 15 298 1.167e-08 2.208e-07
247 REGULATION OF HOMEOSTATIC PROCESS 18 447 1.237e-08 2.329e-07
248 REGULATION OF PROTEIN AUTOPHOSPHORYLATION 7 37 1.241e-08 2.329e-07
249 ALCOHOL METABOLIC PROCESS 16 348 1.335e-08 2.495e-07
250 POSITIVE REGULATION OF NEURON DIFFERENTIATION 15 306 1.663e-08 3.095e-07
251 POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 6 23 1.78e-08 3.3e-07
252 POSITIVE REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 5 12 1.987e-08 3.668e-07
253 RESPONSE TO LIPID 25 888 2.141e-08 3.937e-07
254 PEPTIDYL SERINE MODIFICATION 11 148 2.178e-08 3.99e-07
255 HEART DEVELOPMENT 18 466 2.341e-08 4.272e-07
256 REGULATION OF POSITIVE CHEMOTAXIS 6 24 2.358e-08 4.286e-07
257 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 6 25 3.083e-08 5.582e-07
258 MIDBRAIN DEVELOPMENT 9 90 3.303e-08 5.957e-07
259 PHOSPHATIDYLCHOLINE METABOLIC PROCESS 8 64 3.327e-08 5.976e-07
260 REGULATION OF LIPID METABOLIC PROCESS 14 282 4.362e-08 7.806e-07
261 SECOND MESSENGER MEDIATED SIGNALING 11 160 4.883e-08 8.685e-07
262 POSITIVE REGULATION OF CELL CYCLE 15 332 4.89e-08 8.685e-07
263 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 5 14 4.959e-08 8.774e-07
264 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 6 27 5.088e-08 8.967e-07
265 REGULATION OF CELL JUNCTION ASSEMBLY 8 68 5.412e-08 9.503e-07
266 PHOSPHATIDYLSERINE METABOLIC PROCESS 6 28 6.434e-08 1.125e-06
267 ACTIVATION OF INNATE IMMUNE RESPONSE 12 204 6.647e-08 1.158e-06
268 REGULATION OF DNA METABOLIC PROCESS 15 340 6.679e-08 1.16e-06
269 LIPID CATABOLIC PROCESS 13 247 6.851e-08 1.185e-06
270 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 9 98 6.983e-08 1.203e-06
271 NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY 5 15 7.392e-08 1.269e-06
272 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 10 131 7.548e-08 1.291e-06
273 REGULATION OF PROTEIN LOCALIZATION 25 950 7.914e-08 1.349e-06
274 ACTIN FILAMENT BASED PROCESS 17 450 8.114e-08 1.378e-06
275 COGNITION 13 251 8.264e-08 1.393e-06
276 OSSIFICATION 13 251 8.264e-08 1.393e-06
277 MODULATION OF SYNAPTIC TRANSMISSION 14 301 9.784e-08 1.644e-06
278 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 16 1.069e-07 1.788e-06
279 STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 9 103 1.078e-07 1.797e-06
280 POSITIVE REGULATION OF GENE EXPRESSION 35 1733 1.091e-07 1.814e-06
281 EMBRYONIC ORGAN DEVELOPMENT 16 406 1.127e-07 1.866e-06
282 GROWTH 16 410 1.288e-07 2.125e-06
283 CYTOSKELETON ORGANIZATION 23 838 1.325e-07 2.179e-06
284 PHOSPHATIDYLSERINE ACYL CHAIN REMODELING 5 17 1.504e-07 2.454e-06
285 REGULATION OF ACTIN CYTOSKELETON REORGANIZATION 6 32 1.509e-07 2.454e-06
286 PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING 5 17 1.504e-07 2.454e-06
287 REGULATION OF ACTIN FILAMENT BASED PROCESS 14 312 1.52e-07 2.464e-06
288 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 15 370 1.997e-07 3.227e-06
289 ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 17 482 2.155e-07 3.47e-06
290 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 19 602 2.224e-07 3.568e-06
291 POSITIVE REGULATION OF CELL DEATH 19 605 2.4e-07 3.837e-06
292 INOSITOL PHOSPHATE METABOLIC PROCESS 7 56 2.473e-07 3.94e-06
293 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 22 801 2.529e-07 4.016e-06
294 ALDITOL PHOSPHATE METABOLIC PROCESS 6 35 2.651e-07 4.195e-06
295 REGULATION OF CELL CELL ADHESION 15 380 2.81e-07 4.432e-06
296 VESICLE MEDIATED TRANSPORT 28 1239 2.822e-07 4.436e-06
297 REGULATION OF CELLULAR PROTEIN LOCALIZATION 18 552 2.949e-07 4.62e-06
298 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 9 116 3.005e-07 4.692e-06
299 REGULATION OF CELL CYCLE 24 949 3.074e-07 4.784e-06
300 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 18 554 3.109e-07 4.822e-06
301 ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS 8 85 3.153e-07 4.874e-06
302 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 10 153 3.247e-07 5.002e-06
303 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 9 118 3.478e-07 5.341e-06
304 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 7 59 3.567e-07 5.46e-06
305 EMBRYONIC HEMOPOIESIS 5 20 3.699e-07 5.643e-06
306 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 10 156 3.888e-07 5.912e-06
307 HOMEOSTATIC PROCESS 29 1337 3.922e-07 5.944e-06
308 SINGLE ORGANISM BIOSYNTHETIC PROCESS 29 1340 4.108e-07 6.198e-06
309 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 8 88 4.129e-07 6.198e-06
310 REGULATION OF CATION CHANNEL ACTIVITY 8 88 4.129e-07 6.198e-06
311 APOPTOTIC SIGNALING PATHWAY 13 289 4.188e-07 6.265e-06
312 REGULATION OF ORGAN MORPHOGENESIS 12 242 4.23e-07 6.308e-06
313 REGULATION OF PROTEIN KINASE B SIGNALING 9 121 4.309e-07 6.405e-06
314 POSITIVE REGULATION OF CYCLASE ACTIVITY 7 61 4.503e-07 6.673e-06
315 REGULATION OF ION HOMEOSTASIS 11 201 4.924e-07 7.273e-06
316 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 12 246 5.038e-07 7.418e-06
317 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 18 573 5.079e-07 7.455e-06
318 SKELETAL SYSTEM DEVELOPMENT 16 455 5.211e-07 7.578e-06
319 ASTROCYTE DIFFERENTIATION 6 39 5.194e-07 7.578e-06
320 REGULATION OF DNA REPLICATION 10 161 5.205e-07 7.578e-06
321 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 24 983 5.79e-07 8.393e-06
322 NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 6 40 6.071e-07 8.746e-06
323 POSITIVE REGULATION OF CELL MATRIX ADHESION 6 40 6.071e-07 8.746e-06
324 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 15 406 6.499e-07 9.333e-06
325 SYSTEM PROCESS 34 1785 6.793e-07 9.696e-06
326 EPIDERMIS DEVELOPMENT 12 253 6.786e-07 9.696e-06
327 REPRODUCTIVE SYSTEM DEVELOPMENT 15 408 6.913e-07 9.836e-06
328 REGULATION OF CALCIUM ION TRANSPORT 11 209 7.252e-07 1.029e-05
329 SECRETION 18 588 7.375e-07 1.043e-05
330 RESPONSE TO MECHANICAL STIMULUS 11 210 7.603e-07 1.072e-05
331 REGULATION OF INNATE IMMUNE RESPONSE 14 357 7.724e-07 1.082e-05
332 FOREBRAIN DEVELOPMENT 14 357 7.724e-07 1.082e-05
333 MYELOID LEUKOCYTE DIFFERENTIATION 8 96 8.084e-07 1.13e-05
334 PROTEIN LOCALIZATION 34 1805 8.766e-07 1.221e-05
335 RESPONSE TO OXYGEN LEVELS 13 311 9.579e-07 1.327e-05
336 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 7 68 9.563e-07 1.327e-05
337 REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY 5 24 9.89e-07 1.365e-05
338 EMBRYONIC MORPHOGENESIS 17 539 1.019e-06 1.403e-05
339 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 8 99 1.024e-06 1.405e-05
340 CELLULAR RESPONSE TO STRESS 31 1565 1.033e-06 1.414e-05
341 CHEMICAL HOMEOSTASIS 22 874 1.094e-06 1.493e-05
342 GLIAL CELL DIFFERENTIATION 9 136 1.157e-06 1.574e-05
343 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 7 70 1.167e-06 1.583e-05
344 REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 5 25 1.228e-06 1.662e-05
345 SECRETION BY CELL 16 486 1.239e-06 1.672e-05
346 SPROUTING ANGIOGENESIS 6 45 1.248e-06 1.673e-05
347 SUBSTANTIA NIGRA DEVELOPMENT 6 45 1.248e-06 1.673e-05
348 REGULATED EXOCYTOSIS 11 224 1.434e-06 1.917e-05
349 REGULATION OF SYNAPTIC PLASTICITY 9 140 1.474e-06 1.965e-05
350 SENSORY ORGAN DEVELOPMENT 16 493 1.493e-06 1.984e-05
351 NEGATIVE REGULATION OF CELL COMMUNICATION 26 1192 1.555e-06 2.061e-05
352 CEREBRAL CORTEX DEVELOPMENT 8 105 1.603e-06 2.119e-05
353 POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 6 47 1.624e-06 2.141e-05
354 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 8 106 1.722e-06 2.264e-05
355 REGULATION OF DEFENSE RESPONSE 20 759 1.768e-06 2.318e-05
356 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 11 229 1.778e-06 2.324e-05
357 SINGLE ORGANISM BEHAVIOR 14 384 1.825e-06 2.379e-05
358 RESPONSE TO AMINE 6 48 1.844e-06 2.384e-05
359 POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY 6 48 1.844e-06 2.384e-05
360 REGULATION OF SEQUESTERING OF CALCIUM ION 8 107 1.849e-06 2.384e-05
361 PLATELET DEGRANULATION 8 107 1.849e-06 2.384e-05
362 REGULATION OF CYTOSKELETON ORGANIZATION 16 502 1.887e-06 2.425e-05
363 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 11 232 2.018e-06 2.586e-05
364 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 12 282 2.117e-06 2.706e-05
365 MYELOID CELL DIFFERENTIATION 10 189 2.245e-06 2.862e-05
366 VISUAL BEHAVIOR 6 50 2.358e-06 2.99e-05
367 PHAGOCYTOSIS 10 190 2.354e-06 2.99e-05
368 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 7 78 2.443e-06 3.089e-05
369 POSITIVE REGULATION OF GROWTH 11 238 2.584e-06 3.258e-05
370 SENSORY ORGAN MORPHOGENESIS 11 239 2.691e-06 3.384e-05
371 CELLULAR MACROMOLECULE LOCALIZATION 26 1234 2.937e-06 3.684e-05
372 ACTIVATION OF MAPKK ACTIVITY 6 52 2.983e-06 3.731e-05
373 LEUKOCYTE DIFFERENTIATION 12 292 3.035e-06 3.786e-05
374 RESPONSE TO AMPHETAMINE 5 30 3.194e-06 3.931e-05
375 PHOSPHOLIPID CATABOLIC PROCESS 5 30 3.194e-06 3.931e-05
376 NEPHRON DEVELOPMENT 8 115 3.185e-06 3.931e-05
377 OSTEOCLAST DIFFERENTIATION 5 30 3.194e-06 3.931e-05
378 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 5 30 3.194e-06 3.931e-05
379 RESPIRATORY SYSTEM DEVELOPMENT 10 197 3.256e-06 3.997e-05
380 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 6 53 3.342e-06 4.081e-05
381 MAMMARY GLAND EPITHELIUM DEVELOPMENT 6 53 3.342e-06 4.081e-05
382 JNK CASCADE 7 82 3.425e-06 4.172e-05
383 BONE DEVELOPMENT 9 156 3.612e-06 4.388e-05
384 POSITIVE REGULATION OF CALCIUM ION IMPORT 6 54 3.736e-06 4.527e-05
385 PHOSPHATIDYLGLYCEROL METABOLIC PROCESS 5 31 3.784e-06 4.55e-05
386 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 5 31 3.784e-06 4.55e-05
387 HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE 5 31 3.784e-06 4.55e-05
388 UROGENITAL SYSTEM DEVELOPMENT 12 299 3.871e-06 4.642e-05
389 REGULATION OF AUTOPHAGY 11 249 3.991e-06 4.766e-05
390 REGULATION OF CATABOLIC PROCESS 19 731 3.995e-06 4.766e-05
391 TISSUE MIGRATION 7 84 4.028e-06 4.794e-05
392 NUCLEAR TRANSPORT 13 355 4.126e-06 4.897e-05
393 CELL CHEMOTAXIS 9 162 4.921e-06 5.826e-05
394 REGULATION OF HOMOTYPIC CELL CELL ADHESION 12 307 5.069e-06 5.986e-05
395 PHOSPHATIDIC ACID METABOLIC PROCESS 5 33 5.22e-06 6.149e-05
396 POSITIVE REGULATION OF MITOTIC CELL CYCLE 8 123 5.264e-06 6.185e-05
397 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 10 208 5.279e-06 6.187e-05
398 POSITIVE REGULATION OF DEFENSE RESPONSE 13 364 5.412e-06 6.327e-05
399 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 7 88 5.502e-06 6.4e-05
400 REGULATION OF STEM CELL PROLIFERATION 7 88 5.502e-06 6.4e-05
401 EXOCYTOSIS 12 310 5.596e-06 6.494e-05
402 POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 4 16 5.874e-06 6.799e-05
403 EPITHELIAL CELL PROLIFERATION 7 89 5.933e-06 6.851e-05
404 NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY 5 34 6.082e-06 7.005e-05
405 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 6 59 6.313e-06 7.235e-05
406 VASCULOGENESIS 6 59 6.313e-06 7.235e-05
407 REGULATION OF OXIDOREDUCTASE ACTIVITY 7 90 6.392e-06 7.308e-05
408 REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY 8 127 6.675e-06 7.593e-05
409 POSITIVE REGULATION OF BINDING 8 127 6.675e-06 7.593e-05
410 AMMONIUM ION METABOLIC PROCESS 9 169 6.943e-06 7.879e-05
411 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 6 60 6.97e-06 7.891e-05
412 NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 5 35 7.052e-06 7.964e-05
413 REGULATION OF CELLULAR RESPONSE TO STRESS 18 691 7.092e-06 7.99e-05
414 REPRODUCTION 26 1297 7.198e-06 8.089e-05
415 GLUCOSE HOMEOSTASIS 9 170 7.283e-06 8.146e-05
416 CARBOHYDRATE HOMEOSTASIS 9 170 7.283e-06 8.146e-05
417 POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS 4 17 7.635e-06 8.519e-05
418 POSITIVE REGULATION OF LYASE ACTIVITY 6 61 7.681e-06 8.53e-05
419 POSITIVE REGULATION OF STEM CELL PROLIFERATION 6 61 7.681e-06 8.53e-05
420 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 12 321 7.965e-06 8.824e-05
421 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 14 437 8.08e-06 8.93e-05
422 REGULATION OF SECRETION 18 699 8.295e-06 9.146e-05
423 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 8 131 8.392e-06 9.188e-05
424 AMINE METABOLIC PROCESS 8 131 8.392e-06 9.188e-05
425 LEARNING 8 131 8.392e-06 9.188e-05
426 REGULATION OF METAL ION TRANSPORT 12 325 9.023e-06 9.856e-05
427 POLYOL METABOLIC PROCESS 7 95 9.153e-06 9.974e-05
428 GLIOGENESIS 9 175 9.206e-06 9.985e-05
429 HOMEOSTASIS OF NUMBER OF CELLS 9 175 9.206e-06 9.985e-05
430 MULTICELLULAR ORGANISMAL HOMEOSTASIS 11 272 9.234e-06 9.992e-05
431 POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS 8 133 9.382e-06 0.0001008
432 POSITIVE REGULATION OF CATION CHANNEL ACTIVITY 5 37 9.351e-06 0.0001008
433 POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 8 133 9.382e-06 0.0001008
434 CELLULAR CHEMICAL HOMEOSTASIS 16 570 9.445e-06 0.0001013
435 NEGATIVE REGULATION OF TRANSPORTER ACTIVITY 6 64 1.017e-05 0.0001088
436 GLAND MORPHOGENESIS 7 97 1.05e-05 0.0001118
437 POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 7 97 1.05e-05 0.0001118
438 DEVELOPMENTAL GROWTH 12 333 1.151e-05 0.0001223
439 RESPONSE TO ALKALOID 8 137 1.166e-05 0.0001236
440 TELENCEPHALON DEVELOPMENT 10 228 1.182e-05 0.000125
441 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 7 99 1.202e-05 0.0001268
442 ACTIVATION OF ADENYLATE CYCLASE ACTIVITY 5 39 1.22e-05 0.0001273
443 REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION 4 19 1.228e-05 0.0001273
444 POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 5 39 1.22e-05 0.0001273
445 KIDNEY VASCULATURE DEVELOPMENT 4 19 1.228e-05 0.0001273
446 NEURAL NUCLEUS DEVELOPMENT 6 66 1.217e-05 0.0001273
447 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 4 19 1.228e-05 0.0001273
448 RENAL SYSTEM VASCULATURE DEVELOPMENT 4 19 1.228e-05 0.0001273
449 PEPTIDYL TYROSINE AUTOPHOSPHORYLATION 5 39 1.22e-05 0.0001273
450 ESTABLISHMENT OF PROTEIN LOCALIZATION 27 1423 1.271e-05 0.0001314
451 POSITIVE REGULATION OF NEURON DEATH 6 67 1.329e-05 0.0001371
452 REGULATION OF BINDING 11 283 1.339e-05 0.0001378
453 NEGATIVE REGULATION OF TRANSPORT 14 458 1.369e-05 0.0001406
454 REGULATION OF CALCIUM ION IMPORT 7 103 1.559e-05 0.0001597
455 POSITIVE REGULATION OF ION TRANSPORT 10 236 1.593e-05 0.000163
456 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 7 104 1.66e-05 0.0001694
457 REGULATION OF ADENYLATE CYCLASE ACTIVITY 6 70 1.713e-05 0.0001744
458 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 5 42 1.769e-05 0.0001797
459 STEM CELL DIFFERENTIATION 9 190 1.779e-05 0.0001803
460 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 4 21 1.874e-05 0.0001896
461 POSITIVE REGULATION OF CELL CELL ADHESION 10 243 2.05e-05 0.0002069
462 ASSOCIATIVE LEARNING 6 73 2.182e-05 0.0002197
463 RESPONSE TO INORGANIC SUBSTANCE 14 479 2.251e-05 0.0002256
464 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 7 109 2.255e-05 0.0002256
465 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 7 109 2.255e-05 0.0002256
466 SOMATIC STEM CELL DIVISION 4 22 2.277e-05 0.0002269
467 POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 4 22 2.277e-05 0.0002269
468 REGULATION OF TRANSPORTER ACTIVITY 9 198 2.465e-05 0.0002451
469 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 12 360 2.491e-05 0.0002458
470 POSITIVE REGULATION OF RECEPTOR ACTIVITY 5 45 2.493e-05 0.0002458
471 EXOCRINE SYSTEM DEVELOPMENT 5 45 2.493e-05 0.0002458
472 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 8 152 2.479e-05 0.0002458
473 REGULATION OF CELL ACTIVATION 14 484 2.523e-05 0.0002482
474 CELLULAR GLUCOSE HOMEOSTASIS 6 75 2.548e-05 0.0002496
475 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 6 75 2.548e-05 0.0002496
476 PALLIUM DEVELOPMENT 8 153 2.599e-05 0.0002541
477 RESPONSE TO ALCOHOL 12 362 2.63e-05 0.0002566
478 IMMUNE EFFECTOR PROCESS 14 486 2.64e-05 0.000257
479 RESPONSE TO AMINO ACID 7 112 2.689e-05 0.0002612
480 REGULATION OF APOPTOTIC SIGNALING PATHWAY 12 363 2.702e-05 0.000262
481 AMEBOIDAL TYPE CELL MIGRATION 8 154 2.724e-05 0.0002635
482 REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 4 23 2.74e-05 0.0002645
483 PEPTIDYL THREONINE MODIFICATION 5 46 2.78e-05 0.0002678
484 OVULATION CYCLE 7 113 2.848e-05 0.0002732
485 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 12 365 2.852e-05 0.0002732
486 REGULATION OF CELL PROJECTION ASSEMBLY 8 155 2.853e-05 0.0002732
487 REGULATION OF TRANSMEMBRANE TRANSPORT 13 426 2.861e-05 0.0002734
488 LYMPHOCYTE COSTIMULATION 6 78 3.188e-05 0.000304
489 IN UTERO EMBRYONIC DEVELOPMENT 11 311 3.198e-05 0.0003043
490 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 4 24 3.268e-05 0.0003097
491 POSITIVE REGULATION OF RECEPTOR INTERNALIZATION 4 24 3.268e-05 0.0003097
492 RESPONSE TO STEROID HORMONE 14 497 3.371e-05 0.0003188
493 REGULATION OF RECEPTOR ACTIVITY 7 117 3.564e-05 0.0003357
494 MAMMARY GLAND DEVELOPMENT 7 117 3.564e-05 0.0003357
495 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 6 80 3.683e-05 0.0003462
496 REGULATION OF NEURONAL SYNAPTIC PLASTICITY 5 49 3.796e-05 0.0003546
497 REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 5 49 3.796e-05 0.0003546
498 GLOMERULUS DEVELOPMENT 5 49 3.796e-05 0.0003546
499 POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 4 25 3.867e-05 0.0003598
500 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 4 25 3.867e-05 0.0003598
501 REGULATION OF FIBROBLAST PROLIFERATION 6 81 3.953e-05 0.0003664
502 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 6 81 3.953e-05 0.0003664
503 RESPONSE TO ACID CHEMICAL 11 319 4.029e-05 0.0003727
504 RESPONSE TO CYTOKINE 17 714 4.05e-05 0.0003739
505 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 9 211 4.059e-05 0.000374
506 REGULATION OF ADHERENS JUNCTION ORGANIZATION 5 50 4.191e-05 0.0003839
507 FACE DEVELOPMENT 5 50 4.191e-05 0.0003839
508 REGULATION OF SYSTEM PROCESS 14 507 4.185e-05 0.0003839
509 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 9 213 4.369e-05 0.0003993
510 ORGAN REGENERATION 6 83 4.539e-05 0.0004133
511 EMBRYONIC PLACENTA DEVELOPMENT 6 83 4.539e-05 0.0004133
512 POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION 5 51 4.618e-05 0.0004197
513 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 14 514 4.853e-05 0.0004401
514 EYE DEVELOPMENT 11 326 4.903e-05 0.0004438
515 BEHAVIOR 14 516 5.06e-05 0.0004571
516 POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 5 52 5.077e-05 0.0004579
517 POSITIVE REGULATION OF HEART GROWTH 4 27 5.3e-05 0.0004743
518 REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 4 27 5.3e-05 0.0004743
519 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 4 27 5.3e-05 0.0004743
520 NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 4 27 5.3e-05 0.0004743
521 REGULATION OF LYASE ACTIVITY 6 86 5.547e-05 0.0004947
522 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 5 53 5.571e-05 0.0004947
523 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 5 53 5.571e-05 0.0004947
524 CELLULAR RESPONSE TO AMINO ACID STIMULUS 5 53 5.571e-05 0.0004947
525 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 9 220 5.613e-05 0.0004975
526 TISSUE HOMEOSTASIS 8 171 5.741e-05 0.0005078
527 REGULATION OF ION TRANSPORT 15 592 5.884e-05 0.0005195
528 NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT 6 87 5.92e-05 0.0005217
529 NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY 4 28 6.146e-05 0.0005356
530 REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY 4 28 6.146e-05 0.0005356
531 REGULATION OF SPROUTING ANGIOGENESIS 4 28 6.146e-05 0.0005356
532 MAMMARY GLAND DUCT MORPHOGENESIS 4 28 6.146e-05 0.0005356
533 B CELL RECEPTOR SIGNALING PATHWAY 5 54 6.102e-05 0.0005356
534 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 4 28 6.146e-05 0.0005356
535 OVULATION CYCLE PROCESS 6 88 6.313e-05 0.000549
536 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 5 55 6.67e-05 0.000578
537 ACTIN CYTOSKELETON REORGANIZATION 5 55 6.67e-05 0.000578
538 POSITIVE REGULATION OF CAMP METABOLIC PROCESS 6 89 6.726e-05 0.0005807
539 REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 6 89 6.726e-05 0.0005807
540 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 13 465 7.008e-05 0.0006039
541 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 4 29 7.087e-05 0.0006051
542 STEM CELL DIVISION 4 29 7.087e-05 0.0006051
543 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 4 29 7.087e-05 0.0006051
544 POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY 4 29 7.087e-05 0.0006051
545 NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 4 29 7.087e-05 0.0006051
546 MUSCLE SYSTEM PROCESS 10 282 7.211e-05 0.0006145
547 NEURON NEURON SYNAPTIC TRANSMISSION 5 56 7.279e-05 0.0006192
548 CELLULAR HOMEOSTASIS 16 676 7.401e-05 0.0006284
549 ENDOTHELIAL CELL MIGRATION 5 57 7.929e-05 0.0006708
550 POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 8 179 7.916e-05 0.0006708
551 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 6 92 8.098e-05 0.0006838
552 ESTABLISHMENT OF LOCALIZATION IN CELL 28 1676 8.405e-05 0.0007084
553 REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 9 233 8.723e-05 0.000734
554 NEGATIVE REGULATION OF MOLECULAR FUNCTION 21 1079 9.193e-05 0.0007721
555 REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION 3 12 9.542e-05 0.0007971
556 ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 3 12 9.542e-05 0.0007971
557 NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 3 12 9.542e-05 0.0007971
558 MITOTIC CELL CYCLE 17 766 9.599e-05 0.0008004
559 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 20 1004 0.0001002 0.0008337
560 REGULATION OF MONOOXYGENASE ACTIVITY 5 60 0.0001015 0.000842
561 REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 5 60 0.0001015 0.000842
562 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 21 1087 0.000102 0.0008442
563 SALIVARY GLAND DEVELOPMENT 4 32 0.0001054 0.0008709
564 NEGATIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 5 61 0.0001099 0.000905
565 OVARIAN FOLLICLE DEVELOPMENT 5 61 0.0001099 0.000905
566 NON CANONICAL WNT SIGNALING PATHWAY 7 140 0.0001113 0.0009149
567 RESPONSE TO TOXIC SUBSTANCE 9 241 0.0001128 0.0009254
568 MEMORY 6 98 0.0001151 0.000941
569 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 6 98 0.0001151 0.000941
570 REGULATION OF CELL CYCLE PROCESS 14 558 0.0001161 0.0009474
571 POSITIVE REGULATION OF NUCLEAR DIVISION 5 62 0.0001188 0.000968
572 CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 4 33 0.0001192 0.0009696
573 MESENCHYME DEVELOPMENT 8 190 0.0001199 0.0009733
574 NEURONAL STEM CELL DIVISION 3 13 0.0001233 0.0009929
575 INDUCTION OF POSITIVE CHEMOTAXIS 3 13 0.0001233 0.0009929
576 HEPATOCYTE APOPTOTIC PROCESS 3 13 0.0001233 0.0009929
577 REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING 3 13 0.0001233 0.0009929
578 NEUROBLAST DIVISION 3 13 0.0001233 0.0009929
579 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 6 100 0.0001287 0.001034
580 FOREBRAIN NEURON DEVELOPMENT 4 34 0.0001343 0.001073
581 REGULATION OF MESENCHYMAL CELL PROLIFERATION 4 34 0.0001343 0.001073
582 PROTEIN KINASE B SIGNALING 4 34 0.0001343 0.001073
583 CONNECTIVE TISSUE DEVELOPMENT 8 194 0.0001384 0.001105
584 MUSCLE STRUCTURE DEVELOPMENT 12 432 0.0001423 0.001134
585 REGULATION OF MUSCLE SYSTEM PROCESS 8 195 0.0001434 0.00114
586 BONE REMODELING 4 35 0.0001507 0.001192
587 REGULATION OF GLYCOGEN METABOLIC PROCESS 4 35 0.0001507 0.001192
588 RESPONSE TO MINERALOCORTICOID 4 35 0.0001507 0.001192
589 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 8 197 0.0001538 0.001215
590 REGULATION OF RESPIRATORY BURST 3 14 0.0001561 0.001225
591 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 14 0.0001561 0.001225
592 BONE MATURATION 3 14 0.0001561 0.001225
593 DETECTION OF CALCIUM ION 3 14 0.0001561 0.001225
594 DIGESTIVE SYSTEM DEVELOPMENT 7 148 0.0001573 0.001232
595 SINGLE ORGANISM CATABOLIC PROCESS 19 957 0.0001579 0.001235
596 FOREBRAIN GENERATION OF NEURONS 5 66 0.00016 0.001247
597 REGULATION OF MULTICELLULAR ORGANISM GROWTH 5 66 0.00016 0.001247
598 POSITIVE REGULATION OF CELL ACTIVATION 10 311 0.000161 0.001253
599 REGULATION OF LEUKOCYTE MIGRATION 7 149 0.000164 0.001274
600 OLFACTORY LOBE DEVELOPMENT 4 36 0.0001685 0.001305
601 POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS 4 36 0.0001685 0.001305
602 ENDOCYTOSIS 13 509 0.0001721 0.00133
603 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 5 68 0.0001844 0.001423
604 REGULATION OF RECEPTOR INTERNALIZATION 4 37 0.0001878 0.001442
605 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 4 37 0.0001878 0.001442
606 REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 4 37 0.0001878 0.001442
607 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 3 15 0.000194 0.001481
608 NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 3 15 0.000194 0.001481
609 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 11 381 0.0001942 0.001481
610 REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS 3 15 0.000194 0.001481
611 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 6 108 0.0001963 0.001495
612 CELL CYCLE 23 1316 0.0002059 0.001564
613 POSITIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 6 109 0.0002064 0.001564
614 RESPONSE TO HYDROGEN PEROXIDE 6 109 0.0002064 0.001564
615 POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING 4 38 0.0002086 0.001573
616 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 4 38 0.0002086 0.001573
617 POSITIVE REGULATION OF ORGAN GROWTH 4 38 0.0002086 0.001573
618 REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 7 155 0.0002091 0.001575
619 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 9 262 0.000211 0.001586
620 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 5 70 0.0002114 0.001587
621 INFLAMMATORY RESPONSE 12 454 0.0002249 0.001685
622 SKIN EPIDERMIS DEVELOPMENT 5 71 0.000226 0.001691
623 WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 4 39 0.0002311 0.001718
624 ANATOMICAL STRUCTURE MATURATION 4 39 0.0002311 0.001718
625 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 4 39 0.0002311 0.001718
626 EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 4 39 0.0002311 0.001718
627 SEX DIFFERENTIATION 9 266 0.0002361 0.001752
628 POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION 3 16 0.0002374 0.001753
629 CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE 3 16 0.0002374 0.001753
630 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 3 16 0.0002374 0.001753
631 SKIN DEVELOPMENT 8 211 0.0002456 0.001811
632 MAMMARY GLAND MORPHOGENESIS 4 40 0.0002552 0.001879
633 POSITIVE REGULATION OF STAT CASCADE 5 73 0.0002575 0.001887
634 REGULATION OF ORGAN GROWTH 5 73 0.0002575 0.001887
635 POSITIVE REGULATION OF JAK STAT CASCADE 5 73 0.0002575 0.001887
636 REGULATION OF EMBRYONIC DEVELOPMENT 6 114 0.0002634 0.001927
637 REGENERATION 7 161 0.0002639 0.001928
638 CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS 5 74 0.0002745 0.002002
639 RESPONSE TO CALCIUM ION 6 115 0.0002761 0.002011
640 NEGATIVE REGULATION OF CELL DIFFERENTIATION 14 609 0.0002854 0.002075
641 NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 3 17 0.0002866 0.002078
642 NEGATIVE REGULATION OF ANOIKIS 3 17 0.0002866 0.002078
643 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 8 216 0.0002876 0.002081
644 FEMALE SEX DIFFERENTIATION 6 116 0.0002894 0.002091
645 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 6 117 0.0003031 0.002183
646 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 6 117 0.0003031 0.002183
647 REGULATION OF CELLULAR COMPONENT SIZE 10 337 0.0003064 0.002197
648 RESPONSE TO ESTROGEN 8 218 0.000306 0.002197
649 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 8 218 0.000306 0.002197
650 POSITIVE REGULATION OF DNA BINDING 4 42 0.0003088 0.002207
651 REGULATION OF HEART GROWTH 4 42 0.0003088 0.002207
652 REGULATION OF CALCIUM MEDIATED SIGNALING 5 76 0.0003109 0.002209
653 POSITIVE REGULATION OF TRANSPORTER ACTIVITY 5 76 0.0003109 0.002209
654 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 13 541 0.0003104 0.002209
655 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 13 541 0.0003104 0.002209
656 MESODERM DEVELOPMENT 6 118 0.0003173 0.002251
657 REGULATION OF ANATOMICAL STRUCTURE SIZE 12 472 0.0003202 0.002268
658 REGULATION OF POLYSACCHARIDE METABOLIC PROCESS 4 43 0.0003385 0.00239
659 CEREBRAL CORTEX CELL MIGRATION 4 43 0.0003385 0.00239
660 REGULATION OF COLLATERAL SPROUTING 3 18 0.000342 0.0024
661 REGULATION OF PROTEIN BINDING 7 168 0.0003417 0.0024
662 ORGAN MATURATION 3 18 0.000342 0.0024
663 MAST CELL MEDIATED IMMUNITY 3 18 0.000342 0.0024
664 REGULATION OF DENDRITE DEVELOPMENT 6 120 0.0003473 0.002434
665 DIVALENT INORGANIC CATION HOMEOSTASIS 10 343 0.0003522 0.002464
666 NEGATIVE REGULATION OF CELL ADHESION 8 223 0.0003562 0.002489
667 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 6 121 0.0003631 0.002533
668 LABYRINTHINE LAYER DEVELOPMENT 4 44 0.0003701 0.002574
669 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 4 44 0.0003701 0.002574
670 DENDRITE DEVELOPMENT 5 79 0.0003723 0.002585
671 INTRACELLULAR PROTEIN TRANSPORT 16 781 0.0003803 0.002633
672 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 7 171 0.0003803 0.002633
673 ENDOCRINE SYSTEM DEVELOPMENT 6 123 0.0003964 0.002741
674 DENDRITIC SPINE DEVELOPMENT 3 19 0.0004038 0.002772
675 LUNG MORPHOGENESIS 4 45 0.0004038 0.002772
676 NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 3 19 0.0004038 0.002772
677 MACROPHAGE DIFFERENTIATION 3 19 0.0004038 0.002772
678 NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING 3 19 0.0004038 0.002772
679 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 8 228 0.0004129 0.00283
680 NEGATIVE REGULATION OF HOMEOSTATIC PROCESS 6 124 0.000414 0.002833
681 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 5 81 0.000418 0.002852
682 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 5 81 0.000418 0.002852
683 RESPONSE TO OXIDATIVE STRESS 10 352 0.0004316 0.002941
684 CELLULAR RESPONSE TO ACID CHEMICAL 7 175 0.000437 0.002973
685 RESPONSE TO CORTICOSTEROID 7 176 0.0004522 0.003072
686 NEGATIVE REGULATION OF PHOSPHORYLATION 11 422 0.0004627 0.003138
687 REGULATION OF ERBB SIGNALING PATHWAY 5 83 0.0004678 0.003159
688 HAIR CYCLE 5 83 0.0004678 0.003159
689 MOLTING CYCLE 5 83 0.0004678 0.003159
690 NEGATIVE REGULATION OF ION TRANSPORT 6 127 0.0004702 0.003171
691 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 3 20 0.0004724 0.003181
692 THYMUS DEVELOPMENT 4 47 0.0004776 0.003193
693 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 4 47 0.0004776 0.003193
694 MUSCLE CONTRACTION 8 233 0.0004768 0.003193
695 POSITIVE REGULATION OF DEPHOSPHORYLATION 4 47 0.0004776 0.003193
696 POSITIVE REGULATION OF GLIOGENESIS 4 47 0.0004776 0.003193
697 HEPATICOBILIARY SYSTEM DEVELOPMENT 6 128 0.0004902 0.003273
698 CYTOKINESIS 5 84 0.0004944 0.003296
699 REGULATION OF REPRODUCTIVE PROCESS 6 129 0.0005109 0.003396
700 REGULATION OF CAMP METABOLIC PROCESS 6 129 0.0005109 0.003396
701 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 4 48 0.0005179 0.003428
702 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 4 48 0.0005179 0.003428
703 REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 4 48 0.0005179 0.003428
704 MAST CELL ACTIVATION 3 21 0.000548 0.003617
705 RUFFLE ORGANIZATION 3 21 0.000548 0.003617
706 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 5 86 0.0005508 0.00363
707 RESPONSE TO KETONE 7 182 0.0005524 0.003636
708 REGULATION OF MYELOID CELL DIFFERENTIATION 7 183 0.0005707 0.003745
709 REGULATION OF PROTEIN IMPORT 7 183 0.0005707 0.003745
710 B CELL ACTIVATION 6 132 0.000577 0.003776
711 POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY 6 132 0.000577 0.003776
712 POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 4 50 0.0006057 0.003958
713 NEGATIVE REGULATION OF CELL DEVELOPMENT 9 303 0.0006089 0.003974
714 SINGLE ORGANISM CELLULAR LOCALIZATION 17 898 0.0006118 0.003987
715 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 6 134 0.0006246 0.004059
716 MESENCHYMAL CELL DIFFERENTIATION 6 134 0.0006246 0.004059
717 PROTEIN LOCALIZATION TO CELL SURFACE 3 22 0.000631 0.004083
718 SYNAPTIC TRANSMISSION GLUTAMATERGIC 3 22 0.000631 0.004083
719 ERK1 AND ERK2 CASCADE 3 22 0.000631 0.004083
720 REGULATION OF NEUROTRANSMITTER SECRETION 4 51 0.0006533 0.004195
721 RESPONSE TO NICOTINE 4 51 0.0006533 0.004195
722 INTERSPECIES INTERACTION BETWEEN ORGANISMS 14 662 0.0006537 0.004195
723 NEGATIVE REGULATION OF CALCIUM ION TRANSPORT 4 51 0.0006533 0.004195
724 SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 14 662 0.0006537 0.004195
725 CELL GROWTH 6 135 0.0006495 0.004195
726 REGULATION OF PROTEIN TARGETING 9 307 0.0006686 0.004285
727 EYE MORPHOGENESIS 6 136 0.0006752 0.004322
728 ENDOTHELIUM DEVELOPMENT 5 90 0.0006781 0.004322
729 REGULATION OF GLIOGENESIS 5 90 0.0006781 0.004322
730 MESONEPHROS DEVELOPMENT 5 90 0.0006781 0.004322
731 POSITIVE REGULATION OF CELL CYCLE PROCESS 8 247 0.0006994 0.004452
732 REGULATION OF PROTEIN COMPLEX ASSEMBLY 10 375 0.0007045 0.004478
733 LYSOSOME LOCALIZATION 3 23 0.0007215 0.004574
734 REGULATION OF OSTEOBLAST PROLIFERATION 3 23 0.0007215 0.004574
735 PLACENTA DEVELOPMENT 6 138 0.000729 0.004615
736 RESPONSE TO REACTIVE OXYGEN SPECIES 7 191 0.0007351 0.004647
737 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 4 53 0.0007564 0.004775
738 DEVELOPMENTAL MATURATION 7 193 0.0007815 0.004927
739 REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL 4 54 0.000812 0.005113
740 NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 3 24 0.0008199 0.005135
741 POLYSACCHARIDE CATABOLIC PROCESS 3 24 0.0008199 0.005135
742 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 3 24 0.0008199 0.005135
743 REGULATION OF ANOIKIS 3 24 0.0008199 0.005135
744 EAR DEVELOPMENT 7 195 0.0008303 0.005193
745 RESPONSE TO BACTERIUM 12 528 0.000862 0.005384
746 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 6 143 0.0008779 0.005476
747 REGULATION OF JAK STAT CASCADE 6 144 0.0009103 0.00564
748 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 6 144 0.0009103 0.00564
749 REGULATION OF LEUKOCYTE CHEMOTAXIS 5 96 0.0009087 0.00564
750 REGULATION OF RESPONSE TO CYTOKINE STIMULUS 6 144 0.0009103 0.00564
751 REGULATION OF STAT CASCADE 6 144 0.0009103 0.00564
752 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 8 258 0.0009274 0.005708
753 SINGLE ORGANISM CELL ADHESION 11 459 0.0009238 0.005708
754 NEGATIVE REGULATION OF CALCIUM ION IMPORT 3 25 0.0009264 0.005708
755 EPITHELIAL CELL APOPTOTIC PROCESS 3 25 0.0009264 0.005708
756 THYROID GLAND DEVELOPMENT 3 25 0.0009264 0.005708
757 REGULATION OF PROTEIN SECRETION 10 389 0.0009313 0.005712
758 REGULATION OF DENDRITIC SPINE DEVELOPMENT 4 56 0.0009318 0.005712
759 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 4 56 0.0009318 0.005712
760 CELL DIVISION 11 460 0.0009402 0.005756
761 NEUROMUSCULAR PROCESS 5 97 0.0009522 0.005822
762 REGULATION OF CELL GROWTH 10 391 0.0009681 0.005912
763 RESPONSE TO ESTRADIOL 6 146 0.0009778 0.005963
764 REGULATION OF MUSCLE CONTRACTION 6 147 0.001013 0.00617
765 DEVELOPMENTAL PROGRAMMED CELL DEATH 3 26 0.001041 0.006293
766 REPLACEMENT OSSIFICATION 3 26 0.001041 0.006293
767 RESPONSE TO CORTICOSTERONE 3 26 0.001041 0.006293
768 ENDOCHONDRAL OSSIFICATION 3 26 0.001041 0.006293
769 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 13 616 0.001039 0.006293
770 REGULATION OF CELL FATE COMMITMENT 3 26 0.001041 0.006293
771 MYELOID LEUKOCYTE MIGRATION 5 99 0.001044 0.006299
772 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 7 203 0.00105 0.006311
773 CELLULAR RESPONSE TO ABIOTIC STIMULUS 8 263 0.001049 0.006311
774 NEGATIVE REGULATION OF CATABOLIC PROCESS 7 203 0.00105 0.006311
775 CELLULAR GLUCAN METABOLIC PROCESS 4 58 0.001064 0.006377
776 GLUCAN METABOLIC PROCESS 4 58 0.001064 0.006377
777 REGULATION OF MITOTIC CELL CYCLE 11 468 0.00108 0.00647
778 NEURAL TUBE DEVELOPMENT 6 149 0.001086 0.00648
779 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 10 397 0.001086 0.00648
780 BIOLOGICAL ADHESION 18 1032 0.001085 0.00648
781 LIMBIC SYSTEM DEVELOPMENT 5 100 0.001092 0.006505
782 POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS 4 59 0.001134 0.006748
783 REGULATION OF LEUKOCYTE PROLIFERATION 7 206 0.001143 0.006783
784 REGULATION OF EXTENT OF CELL GROWTH 5 101 0.001142 0.006783
785 REGULATION OF LAMELLIPODIUM ASSEMBLY 3 27 0.001165 0.006905
786 STEM CELL PROLIFERATION 4 60 0.001208 0.007141
787 CHONDROCYTE DIFFERENTIATION 4 60 0.001208 0.007141
788 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 26 1784 0.001245 0.00735
789 REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 4 61 0.001285 0.007568
790 CELLULAR RESPONSE TO HYDROGEN PEROXIDE 4 61 0.001285 0.007568
791 REGULATION OF NEUROBLAST PROLIFERATION 3 28 0.001297 0.007631
792 POSITIVE REGULATION OF PROTEIN IMPORT 5 104 0.001301 0.007635
793 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 5 104 0.001301 0.007635
794 FOREBRAIN CELL MIGRATION 4 62 0.001365 0.007991
795 REGULATION OF SMOOTHENED SIGNALING PATHWAY 4 62 0.001365 0.007991
796 NEGATIVE REGULATION OF RECEPTOR ACTIVITY 3 29 0.001439 0.0084
797 NEUROBLAST PROLIFERATION 3 29 0.001439 0.0084
798 REGULATION OF OSTEOCLAST DIFFERENTIATION 4 63 0.001449 0.008449
799 RESPONSE TO BIOTIC STIMULUS 16 886 0.001451 0.008449
800 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 7 216 0.001501 0.008731
801 EMBRYONIC ORGAN MORPHOGENESIS 8 279 0.001527 0.008869
802 REGULATION OF CYTOKINESIS 4 64 0.001537 0.008904
803 REGULATION OF NEUROTRANSMITTER TRANSPORT 4 64 0.001537 0.008904
804 LEUKOCYTE DEGRANULATION 3 30 0.00159 0.009109
805 RESPONSE TO MORPHINE 3 30 0.00159 0.009109
806 RESPONSE TO EPIDERMAL GROWTH FACTOR 3 30 0.00159 0.009109
807 NEGATIVE REGULATION OF CELL MATRIX ADHESION 3 30 0.00159 0.009109
808 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 3 30 0.00159 0.009109
809 MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 3 30 0.00159 0.009109
810 REGULATION OF DENDRITIC SPINE MORPHOGENESIS 3 30 0.00159 0.009109
811 RESPONSE TO ISOQUINOLINE ALKALOID 3 30 0.00159 0.009109
812 REGULATION OF VASCULAR PERMEABILITY 3 30 0.00159 0.009109
813 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 4 65 0.001628 0.009304
814 NEGATIVE REGULATION OF AXONOGENESIS 4 65 0.001628 0.009304
815 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 5 110 0.001669 0.009527
816 EPITHELIAL CELL DIFFERENTIATION 11 495 0.001687 0.009622
817 WNT SIGNALING PATHWAY 9 351 0.001701 0.009685
818 ACID SECRETION 4 66 0.001722 0.009773
819 REGULATION OF CARDIAC MUSCLE CONTRACTION 4 66 0.001722 0.009773
820 REGULATION OF CARDIAC CONDUCTION 4 66 0.001722 0.009773
821 ANATOMICAL STRUCTURE HOMEOSTASIS 8 285 0.001745 0.00989
822 EYE PHOTORECEPTOR CELL DEVELOPMENT 3 31 0.00175 0.009894
823 REGULATION OF SYNAPTIC VESICLE TRANSPORT 3 31 0.00175 0.009894
824 SYNAPTIC SIGNALING 10 424 0.00177 0.009993
NumGOOverlapSizeP ValueAdj. P Value
1 KINASE ACTIVITY 59 842 7.3e-41 6.781e-38
2 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 59 992 7.606e-37 3.533e-34
3 PROTEIN KINASE ACTIVITY 48 640 4.082e-34 1.264e-31
4 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 33 228 1.184e-32 2.749e-30
5 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 36 303 1.791e-32 3.328e-30
6 MOLECULAR FUNCTION REGULATOR 62 1353 2.276e-32 3.524e-30
7 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 22 70 4.905e-30 6.51e-28
8 RECEPTOR BINDING 58 1476 1.445e-26 1.678e-24
9 PROTEIN TYROSINE KINASE ACTIVITY 26 176 4.899e-26 5.057e-24
10 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 17 43 1.889e-25 1.755e-23
11 GROWTH FACTOR ACTIVITY 24 160 2.999e-24 2.533e-22
12 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 17 51 6.288e-24 4.868e-22
13 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 17 64 5.392e-22 3.853e-20
14 RIBONUCLEOTIDE BINDING 58 1860 1.665e-21 1.105e-19
15 SIGNAL TRANSDUCER ACTIVITY 56 1731 1.915e-21 1.186e-19
16 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 17 81 4.492e-20 2.608e-18
17 ENZYME BINDING 54 1737 8.118e-20 4.436e-18
18 KINASE BINDING 33 606 5.781e-19 2.984e-17
19 RECEPTOR SIGNALING PROTEIN ACTIVITY 20 172 4.288e-18 2.096e-16
20 GROWTH FACTOR RECEPTOR BINDING 16 129 3.875e-15 1.8e-13
21 PROTEIN TYROSINE KINASE BINDING 12 54 7.903e-15 3.496e-13
22 NEUROTROPHIN RECEPTOR BINDING 8 14 3.131e-14 1.322e-12
23 ADENYL NUCLEOTIDE BINDING 43 1514 3.357e-14 1.356e-12
24 PHOSPHOLIPASE ACTIVITY 13 94 3.836e-13 1.485e-11
25 PROTEIN SERINE THREONINE KINASE ACTIVITY 23 445 6.151e-13 2.286e-11
26 GTPASE ACTIVITY 18 246 7.436e-13 2.657e-11
27 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 12 92 6.499e-12 2.236e-10
28 LIPASE ACTIVITY 13 117 6.769e-12 2.246e-10
29 GROWTH FACTOR BINDING 13 123 1.291e-11 4.134e-10
30 ENZYME ACTIVATOR ACTIVITY 22 471 1.493e-11 4.624e-10
31 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING 8 28 2.957e-11 8.861e-10
32 KINASE ACTIVATOR ACTIVITY 10 62 4.44e-11 1.289e-09
33 ENZYME REGULATOR ACTIVITY 30 959 5.205e-11 1.465e-09
34 INSULIN RECEPTOR SUBSTRATE BINDING 6 11 8.797e-11 2.404e-09
35 KINASE REGULATOR ACTIVITY 14 186 2.043e-10 5.423e-09
36 PHOSPHATIDYLINOSITOL 3 KINASE BINDING 7 30 2.569e-09 6.629e-08
37 PHOSPHOLIPASE A2 ACTIVITY 7 31 3.297e-09 8.278e-08
38 PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY 6 19 4.908e-09 1.2e-07
39 PHOSPHATIDYLCHOLINE 1 ACYLHYDROLASE ACTIVITY 5 11 1.166e-08 2.778e-07
40 HEPARIN BINDING 11 157 4.017e-08 9.329e-07
41 THIOESTERASE BINDING 5 14 4.959e-08 1.124e-06
42 CHEMOATTRACTANT ACTIVITY 6 27 5.088e-08 1.125e-06
43 GUANYL NUCLEOTIDE BINDING 16 390 6.504e-08 1.405e-06
44 INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING 5 15 7.392e-08 1.526e-06
45 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 5 15 7.392e-08 1.526e-06
46 INSULIN RECEPTOR BINDING 6 32 1.509e-07 2.982e-06
47 GTP DEPENDENT PROTEIN BINDING 5 17 1.504e-07 2.982e-06
48 CYTOKINE RECEPTOR BINDING 13 271 2.008e-07 3.886e-06
49 SULFUR COMPOUND BINDING 12 234 2.951e-07 5.595e-06
50 GLYCOSAMINOGLYCAN BINDING 11 205 5.989e-07 1.113e-05
51 EPHRIN RECEPTOR BINDING 5 24 9.89e-07 1.801e-05
52 GDP BINDING 6 51 2.655e-06 4.744e-05
53 MAP KINASE ACTIVITY 4 14 3.27e-06 5.732e-05
54 PROTEIN HETERODIMERIZATION ACTIVITY 15 468 3.76e-06 6.469e-05
55 PROTEIN PHOSPHATASE BINDING 8 120 4.38e-06 7.398e-05
56 PHOSPHATASE BINDING 9 162 4.921e-06 8.163e-05
57 IDENTICAL PROTEIN BINDING 25 1209 6.491e-06 0.0001058
58 PROTEIN DIMERIZATION ACTIVITY 24 1149 8.608e-06 0.0001379
59 GLUTAMATE RECEPTOR BINDING 5 37 9.351e-06 0.0001472
60 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 12 329 1.02e-05 0.000158
61 CARBOXYLIC ESTER HYDROLASE ACTIVITY 8 135 1.047e-05 0.0001594
62 PROTEIN COMPLEX BINDING 21 935 1.141e-05 0.000171
63 PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY 5 39 1.22e-05 0.0001783
64 PHOSPHOLIPASE BINDING 4 19 1.228e-05 0.0001783
65 PROTEIN N TERMINUS BINDING 7 103 1.559e-05 0.0002228
66 HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES 19 820 2.018e-05 0.0002841
67 SIGNALING ADAPTOR ACTIVITY 6 74 2.359e-05 0.0003271
68 PROTEIN DOMAIN SPECIFIC BINDING 16 624 2.861e-05 0.0003909
69 PHOSPHATASE ACTIVATOR ACTIVITY 3 11 7.197e-05 0.0009417
70 DIACYLGLYCEROL BINDING 3 11 7.197e-05 0.0009417
71 INOSITOL TRISPHOSPHATE KINASE ACTIVITY 3 11 7.197e-05 0.0009417
72 CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY 3 12 9.542e-05 0.001214
73 MAP KINASE KINASE ACTIVITY 3 12 9.542e-05 0.001214
74 GTPASE BINDING 10 295 0.0001046 0.001314
75 PROTEIN HOMODIMERIZATION ACTIVITY 16 722 0.0001581 0.001933
76 TITIN BINDING 3 14 0.0001561 0.001933
77 PROTEIN KINASE C ACTIVITY 3 16 0.0002374 0.002828
78 PHOSPHATIDYLINOSITOL PHOSPHATE KINASE ACTIVITY 3 16 0.0002374 0.002828
79 NITRIC OXIDE SYNTHASE BINDING 3 19 0.0004038 0.004749
80 LYSOPHOSPHOLIPASE ACTIVITY 3 20 0.0004724 0.005486
81 HYDROLASE ACTIVITY ACTING ON ESTER BONDS 15 739 0.0006398 0.007338
82 PHOSPHORIC DIESTER HYDROLASE ACTIVITY 5 90 0.0006781 0.007682
83 FIBROBLAST GROWTH FACTOR BINDING 3 23 0.0007215 0.008076
NumGOOverlapSizeP ValueAdj. P Value
1 CYTOPLASMIC SIDE OF MEMBRANE 22 170 7.602e-21 4.44e-18
2 SIDE OF MEMBRANE 25 428 3.374e-15 9.852e-13
3 EXTRINSIC COMPONENT OF MEMBRANE 19 252 9.585e-14 1.866e-11
4 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 12 98 1.398e-11 2.041e-09
5 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 13 136 4.664e-11 5.448e-09
6 INTRINSIC COMPONENT OF THE CYTOPLASMIC SIDE OF THE PLASMA MEMBRANE 6 15 9.289e-10 9.041e-08
7 MEMBRANE REGION 30 1134 2.816e-09 2.35e-07
8 CELL JUNCTION 30 1151 3.973e-09 2.721e-07
9 HETEROTRIMERIC G PROTEIN COMPLEX 7 32 4.193e-09 2.721e-07
10 PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX 6 20 6.967e-09 4.069e-07
11 INTRACELLULAR VESICLE 31 1259 7.982e-09 4.238e-07
12 CELL SUBSTRATE JUNCTION 17 398 1.362e-08 6.5e-07
13 CELL LEADING EDGE 16 350 1.447e-08 6.5e-07
14 INTRINSIC COMPONENT OF PLASMA MEMBRANE 35 1649 3.198e-08 1.334e-06
15 PLASMA MEMBRANE REGION 25 929 5.149e-08 2.005e-06
16 CELL PROJECTION 35 1786 2.264e-07 8.264e-06
17 ANCHORING JUNCTION 17 489 2.64e-07 9.069e-06
18 TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS 12 237 3.383e-07 1.098e-05
19 VACUOLE 27 1180 3.736e-07 1.12e-05
20 MEMBRANE MICRODOMAIN 13 288 4.026e-07 1.12e-05
21 RUFFLE 10 156 3.888e-07 1.12e-05
22 PLASMA MEMBRANE PROTEIN COMPLEX 17 510 4.751e-07 1.261e-05
23 MEMBRANE PROTEIN COMPLEX 24 1020 1.115e-06 2.713e-05
24 CELL PROJECTION PART 23 946 1.1e-06 2.713e-05
25 CELL SURFACE 20 757 1.698e-06 3.968e-05
26 PERINUCLEAR REGION OF CYTOPLASM 18 642 2.566e-06 5.763e-05
27 ENDOSOME 19 793 1.268e-05 0.0002743
28 NEURON PART 25 1265 1.411e-05 0.0002942
29 VESICLE LUMEN 7 106 1.88e-05 0.0003786
30 RUFFLE MEMBRANE 6 80 3.683e-05 0.000717
31 NEURONAL POSTSYNAPTIC DENSITY 5 53 5.571e-05 0.001037
32 EXTRACELLULAR SPACE 25 1376 5.681e-05 0.001037
33 PLATELET ALPHA GRANULE LUMEN 5 55 6.67e-05 0.00118
34 PROTEIN KINASE COMPLEX 6 90 7.161e-05 0.001201
35 IKAPPAB KINASE COMPLEX 3 11 7.197e-05 0.001201
36 SYNAPSE 17 754 7.925e-05 0.001286
37 LEADING EDGE MEMBRANE 7 134 8.454e-05 0.001334
38 EARLY ENDOSOME 10 301 0.0001234 0.001897
39 CATALYTIC COMPLEX 20 1038 0.0001566 0.002345
40 SITE OF POLARIZED GROWTH 7 149 0.000164 0.002394
41 ACTIN FILAMENT 5 70 0.0002114 0.003011
42 RECEPTOR COMPLEX 10 327 0.0002411 0.003352
43 SECRETORY VESICLE 12 461 0.0002586 0.003512
44 PLATELET ALPHA GRANULE 5 75 0.0002922 0.003879
45 GOLGI APPARATUS 24 1445 0.0003152 0.00409
46 NEURON PROJECTION 18 942 0.0003765 0.004779
47 LAMELLIPODIUM 7 172 0.0003939 0.004894
48 CYTOPLASMIC REGION 9 287 0.000412 0.005013
49 SECRETORY GRANULE LUMEN 5 85 0.000522 0.005957
50 CELL PROJECTION MEMBRANE 9 298 0.0005405 0.005957
51 CELL CORTEX 8 238 0.0005485 0.005957
52 SOMATODENDRITIC COMPARTMENT 14 650 0.0005465 0.005957
53 MAST CELL GRANULE 3 21 0.000548 0.005957
54 PLASMA MEMBRANE RAFT 5 86 0.0005508 0.005957
55 CYTOPLASMIC VESICLE PART 13 601 0.0008306 0.008819
56 EXCITATORY SYNAPSE 7 197 0.0008814 0.009037
57 ENDOCYTIC VESICLE 8 256 0.0008821 0.009037

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04014_Ras_signaling_pathway 155 236 0 0
2 hsa04151_PI3K_AKT_signaling_pathway 79 351 1.722e-98 1.55e-96
3 hsa04010_MAPK_signaling_pathway 61 268 1.241e-74 7.443e-73
4 hsa04722_Neurotrophin_signaling_pathway 40 127 1.659e-54 7.467e-53
5 hsa04510_Focal_adhesion 45 200 5.346e-54 1.925e-52
6 hsa04012_ErbB_signaling_pathway 35 87 4.001e-52 1.2e-50
7 hsa04810_Regulation_of_actin_cytoskeleton 44 214 7.139e-51 1.836e-49
8 hsa04062_Chemokine_signaling_pathway 40 189 1.093e-46 2.459e-45
9 hsa04664_Fc_epsilon_RI_signaling_pathway 29 79 9.4e-42 1.88e-40
10 hsa04370_VEGF_signaling_pathway 26 76 1.64e-36 2.953e-35
11 hsa04662_B_cell_receptor_signaling_pathway 25 75 8.606e-35 1.408e-33
12 hsa04910_Insulin_signaling_pathway 28 138 4.372e-32 6.559e-31
13 hsa04660_T_cell_receptor_signaling_pathway 26 108 6.035e-32 8.357e-31
14 hsa04666_Fc_gamma_R.mediated_phagocytosis 24 95 4.269e-30 5.488e-29
15 hsa04650_Natural_killer_cell_mediated_cytotoxicity 26 136 4.187e-29 5.025e-28
16 hsa04912_GnRH_signaling_pathway 23 101 1.014e-27 1.14e-26
17 hsa04380_Osteoclast_differentiation 22 128 1.179e-23 1.249e-22
18 hsa04914_Progesterone.mediated_oocyte_maturation 19 87 1.131e-22 1.131e-21
19 hsa04620_Toll.like_receptor_signaling_pathway 18 102 9.619e-20 9.113e-19
20 hsa04720_Long.term_potentiation 16 70 1.33e-19 1.197e-18
21 hsa04210_Apoptosis 17 89 2.515e-19 2.156e-18
22 hsa04540_Gap_junction 17 90 3.081e-19 2.52e-18
23 hsa04360_Axon_guidance 19 130 3.691e-19 2.889e-18
24 hsa04960_Aldosterone.regulated_sodium_reabsorption 13 42 4.586e-18 3.439e-17
25 hsa04070_Phosphatidylinositol_signaling_system 15 78 3.147e-17 2.266e-16
26 hsa04670_Leukocyte_transendothelial_migration 17 117 3.303e-17 2.287e-16
27 hsa04150_mTOR_signaling_pathway 13 52 1.068e-16 7.12e-16
28 hsa04916_Melanogenesis 15 101 1.842e-15 1.184e-14
29 hsa04730_Long.term_depression 13 70 7.086e-15 4.398e-14
30 hsa04270_Vascular_smooth_muscle_contraction 15 116 1.543e-14 9.259e-14
31 hsa04020_Calcium_signaling_pathway 17 177 3.89e-14 2.259e-13
32 hsa04144_Endocytosis 16 203 4.838e-12 2.721e-11
33 hsa04320_Dorso.ventral_axis_formation 8 25 1.049e-11 5.724e-11
34 hsa04973_Carbohydrate_digestion_and_absorption 9 44 4.489e-11 2.376e-10
35 hsa04920_Adipocytokine_signaling_pathway 10 68 1.154e-10 5.934e-10
36 hsa04520_Adherens_junction 10 73 2.386e-10 1.193e-09
37 hsa04310_Wnt_signaling_pathway 12 151 2.269e-09 1.104e-08
38 hsa04630_Jak.STAT_signaling_pathway 12 155 3.06e-09 1.449e-08
39 hsa04530_Tight_junction 11 133 7.104e-09 3.279e-08
40 hsa04621_NOD.like_receptor_signaling_pathway 8 59 1.722e-08 7.749e-08
41 hsa04972_Pancreatic_secretion 9 101 9.085e-08 3.989e-07
42 hsa04971_Gastric_acid_secretion 8 74 1.061e-07 4.547e-07
43 hsa04114_Oocyte_meiosis 9 114 2.589e-07 1.084e-06
44 hsa04970_Salivary_secretion 8 89 4.507e-07 1.844e-06
45 hsa04622_RIG.I.like_receptor_signaling_pathway 7 71 1.287e-06 5.146e-06
46 hsa00562_Inositol_phosphate_metabolism 6 57 5.15e-06 2.015e-05
47 hsa00565_Ether_lipid_metabolism 5 36 8.138e-06 3.117e-05
48 hsa04744_Phototransduction 4 29 7.087e-05 0.0002658
49 hsa04962_Vasopressin.regulated_water_reabsorption 4 44 0.0003701 0.00136
50 hsa00564_Glycerophospholipid_metabolism 5 80 0.0003946 0.001421
51 hsa00592_alpha.Linolenic_acid_metabolism 3 20 0.0004724 0.001667
52 hsa04623_Cytosolic_DNA.sensing_pathway 4 56 0.0009318 0.003225
53 hsa00591_Linoleic_acid_metabolism 3 30 0.00159 0.005399
54 hsa04640_Hematopoietic_cell_lineage 4 88 0.004888 0.01629
55 hsa04975_Fat_digestion_and_absorption 3 46 0.00543 0.01777
56 hsa00590_Arachidonic_acid_metabolism 3 59 0.01081 0.03475
57 hsa04742_Taste_transduction 2 52 0.06152 0.1943
58 hsa04340_Hedgehog_signaling_pathway 2 56 0.07004 0.2174
59 hsa04976_Bile_secretion 2 71 0.105 0.3203
60 hsa04145_Phagosome 3 156 0.1211 0.3633
61 hsa04350_TGF.beta_signaling_pathway 2 85 0.1409 0.4123
62 hsa04141_Protein_processing_in_endoplasmic_reticulum 3 168 0.142 0.4123
63 hsa04740_Olfactory_transduction 5 388 0.1836 0.5246
64 hsa04390_Hippo_signaling_pathway 2 154 0.3356 0.9437

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

PCA3

hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-3662;hsa-miR-424-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-616-5p;hsa-miR-944 20 FGF7 Sponge network -2.778 8.0E-5 -1.56 0.00499 0.493
2

RFPL1S

hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-505-3p 11 AKT3 Sponge network -0.223 0.70704 -0.749 0.06936 0.466
3

MEG3

hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-31-5p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-3662;hsa-miR-429;hsa-miR-577;hsa-miR-616-5p;hsa-miR-7-1-3p 16 FGF7 Sponge network -1.645 0.00049 -1.56 0.00499 0.458
4

PCA3

hsa-miR-1254;hsa-miR-1271-5p;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-200a-3p;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-23a-3p;hsa-miR-590-3p;hsa-miR-616-5p;hsa-miR-671-5p;hsa-miR-939-5p;hsa-miR-940;hsa-miR-96-5p 19 GNG7 Sponge network -2.778 8.0E-5 -3.457 0 0.457
5

PCA3

hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-128-3p;hsa-miR-130b-3p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-335-5p;hsa-miR-590-3p;hsa-miR-671-5p 15 KIT Sponge network -2.778 8.0E-5 -3.335 0 0.45
6

MEG3

hsa-miR-130b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-652-3p;hsa-miR-7-1-3p;hsa-miR-96-5p 11 MRAS Sponge network -1.645 0.00049 -0.939 0.01023 0.445
7 CASC2 hsa-miR-183-5p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-218-5p;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-2355-3p;hsa-miR-24-2-5p;hsa-miR-369-3p;hsa-miR-452-5p;hsa-miR-654-3p;hsa-miR-944 12 PRKCA Sponge network -0.561 0.05962 -0.525 0.15685 0.436
8

MEG3

hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-3662;hsa-miR-577;hsa-miR-592;hsa-miR-629-5p 13 IGF1 Sponge network -1.645 0.00049 -2.083 0.00135 0.434
9

PCA3

hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-330-3p;hsa-miR-335-5p;hsa-miR-3662;hsa-miR-3682-3p;hsa-miR-424-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-3p 28 FGF2 Sponge network -2.778 8.0E-5 -1.879 0.00013 0.416
10

MEG3

hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-3662;hsa-miR-429;hsa-miR-577;hsa-miR-93-3p 19 FGF2 Sponge network -1.645 0.00049 -1.879 0.00013 0.415
11

MEG3

hsa-miR-106b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-577 11 FGFR1 Sponge network -1.645 0.00049 -1.499 0.00051 0.412
12

PCA3

hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-181b-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-3662;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-5p;hsa-miR-940 24 IGF1 Sponge network -2.778 8.0E-5 -2.083 0.00135 0.404
13

PCA3

hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-1254;hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-200b-3p;hsa-miR-224-5p;hsa-miR-23a-3p;hsa-miR-25-3p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-5p 19 GRIN2A Sponge network -2.778 8.0E-5 -3.62 0 0.401
14

EMX2OS

hsa-miR-107;hsa-miR-1254;hsa-miR-130b-5p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-200b-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-577;hsa-miR-877-5p;hsa-miR-92a-3p 11 GRIN2A Sponge network -1.088 0.10042 -3.62 0 0.393
15

PCA3

hsa-miR-141-5p;hsa-miR-16-2-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-452-3p;hsa-miR-589-3p;hsa-miR-589-5p;hsa-miR-590-5p;hsa-miR-616-5p 12 PRKCB Sponge network -2.778 8.0E-5 -1.403 0.00367 0.387
16

DGCR5

hsa-miR-107;hsa-miR-140-3p;hsa-miR-148a-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-326;hsa-miR-338-3p;hsa-miR-362-5p;hsa-miR-501-5p;hsa-miR-577 10 NTRK2 Sponge network 1.383 0.01835 0.129 0.90432 0.38
17

MEG3

hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-20a-5p;hsa-miR-219a-5p;hsa-miR-335-3p;hsa-miR-93-5p;hsa-miR-96-5p 14 PDGFRA Sponge network -1.645 0.00049 -1.161 0.00469 0.38
18

DGCR5

hsa-let-7g-5p;hsa-miR-140-3p;hsa-miR-148a-5p;hsa-miR-150-5p;hsa-miR-192-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-215-5p;hsa-miR-30d-5p;hsa-miR-362-3p;hsa-miR-375;hsa-miR-500a-3p;hsa-miR-577;hsa-miR-592;hsa-miR-625-5p;hsa-miR-7-5p 16 IGF1R Sponge network 1.383 0.01835 -0.553 0.17433 0.365
19

EMX2OS

hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-192-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-21-3p;hsa-miR-215-5p;hsa-miR-222-3p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-424-5p;hsa-miR-503-5p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-92a-3p;hsa-miR-93-3p 22 FGF2 Sponge network -1.088 0.10042 -1.879 0.00013 0.362
20

EMX2OS

hsa-miR-107;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-362-3p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-505-3p;hsa-miR-577 12 AKT3 Sponge network -1.088 0.10042 -0.749 0.06936 0.354
21

PCA3

hsa-let-7b-5p;hsa-let-7d-5p;hsa-miR-1301-3p;hsa-miR-130b-5p;hsa-miR-134-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-2355-3p;hsa-miR-296-5p;hsa-miR-452-3p;hsa-miR-589-3p;hsa-miR-629-3p;hsa-miR-93-3p;hsa-miR-940 17 GAB2 Sponge network -2.778 8.0E-5 -1.242 0.00013 0.342
22 HAR1A hsa-miR-1254;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-224-5p;hsa-miR-671-5p;hsa-miR-940 11 GNG7 Sponge network -0.801 0.17598 -3.457 0 0.341
23

EMX2OS

hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-424-5p;hsa-miR-577;hsa-miR-7-1-3p 10 FGF7 Sponge network -1.088 0.10042 -1.56 0.00499 0.338
24

AGAP11

hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-181b-5p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-320b;hsa-miR-3662;hsa-miR-421;hsa-miR-629-5p 14 IGF1 Sponge network -1.728 0.00016 -2.083 0.00135 0.332
25

AGAP11

hsa-miR-16-1-3p;hsa-miR-18a-5p;hsa-miR-222-5p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-320b;hsa-miR-326;hsa-miR-532-3p;hsa-miR-590-5p;hsa-miR-629-5p 10 FGF1 Sponge network -1.728 0.00016 -0.16 0.73397 0.329
26

EMX2OS

hsa-miR-1254;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-200a-3p;hsa-miR-3127-5p;hsa-miR-92a-3p 10 GNG7 Sponge network -1.088 0.10042 -3.457 0 0.327
27

RFPL1S

hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-18a-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29b-1-5p;hsa-miR-34a-5p;hsa-miR-429;hsa-miR-7-1-3p 12 GAB1 Sponge network -0.223 0.70704 -0.958 0.00019 0.32
28

RFPL1S

hsa-miR-107;hsa-miR-192-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-215-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-5p;hsa-miR-335-5p;hsa-miR-429 12 FGF2 Sponge network -0.223 0.70704 -1.879 0.00013 0.314
29

MEG3

hsa-miR-106b-5p;hsa-miR-107;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-320b;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-577;hsa-miR-616-5p 11 AKT3 Sponge network -1.645 0.00049 -0.749 0.06936 0.312
30

PCA3

hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-149-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-20a-5p;hsa-miR-219a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-944;hsa-miR-96-5p 26 PDGFRA Sponge network -2.778 8.0E-5 -1.161 0.00469 0.31
31

PCA3

hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-128-3p;hsa-miR-144-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-188-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-324-3p;hsa-miR-330-3p;hsa-miR-424-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-96-5p 28 PIK3R1 Sponge network -2.778 8.0E-5 -1.094 2.0E-5 0.309
32 NEAT1 hsa-let-7b-5p;hsa-let-7d-5p;hsa-miR-1301-3p;hsa-miR-130b-5p;hsa-miR-134-5p;hsa-miR-181b-5p;hsa-miR-185-3p;hsa-miR-296-5p;hsa-miR-452-3p;hsa-miR-629-3p;hsa-miR-93-3p;hsa-miR-940 12 GAB2 Sponge network -0.686 0.02293 -1.242 0.00013 0.302
33

RFPL1S

hsa-miR-126-5p;hsa-miR-18a-5p;hsa-miR-222-5p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-429;hsa-miR-532-3p;hsa-miR-550a-5p;hsa-miR-625-5p;hsa-miR-7-5p 12 FGF1 Sponge network -0.223 0.70704 -0.16 0.73397 0.3
34

MEG3

hsa-let-7d-5p;hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-128-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-200a-5p;hsa-miR-200b-3p;hsa-miR-200b-5p;hsa-miR-200c-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-7-1-3p 17 ABL2 Sponge network -1.645 0.00049 0.257 0.18922 0.297
35

RFPL1S

hsa-miR-106b-5p;hsa-miR-107;hsa-miR-126-5p;hsa-miR-1266-5p;hsa-miR-148a-5p;hsa-miR-17-3p;hsa-miR-188-5p;hsa-miR-200a-5p;hsa-miR-200b-3p;hsa-miR-200b-5p;hsa-miR-200c-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-30d-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-378c;hsa-miR-429;hsa-miR-7-1-3p 20 ABL2 Sponge network -0.223 0.70704 0.257 0.18922 0.29
36

AGAP11

hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-25-3p;hsa-miR-320b;hsa-miR-335-3p;hsa-miR-590-5p;hsa-miR-629-5p 10 GRIN2A Sponge network -1.728 0.00016 -3.62 0 0.283
37

EMX2OS

hsa-miR-135b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-335-3p;hsa-miR-577 10 FGFR1 Sponge network -1.088 0.10042 -1.499 0.00051 0.281
38

EMX2OS

hsa-miR-15a-5p;hsa-miR-192-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-196a-5p;hsa-miR-215-5p;hsa-miR-335-3p;hsa-miR-34a-5p;hsa-miR-362-3p;hsa-miR-500a-3p;hsa-miR-577;hsa-miR-592;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-7-5p;hsa-miR-877-5p 16 IGF1R Sponge network -1.088 0.10042 -0.553 0.17433 0.28
39

PCA3

hsa-miR-183-5p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-200c-3p;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-2355-3p;hsa-miR-369-3p;hsa-miR-590-3p;hsa-miR-93-3p;hsa-miR-944 11 PRKCA Sponge network -2.778 8.0E-5 -0.525 0.15685 0.278
40

PCA3

hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-96-5p 10 RGL1 Sponge network -2.778 8.0E-5 -0.192 0.50814 0.274
41

AGAP11

hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-29b-1-5p;hsa-miR-335-3p;hsa-miR-93-5p 11 GAB1 Sponge network -1.728 0.00016 -0.958 0.00019 0.269
42

PCA3

hsa-miR-1180-3p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-193b-3p;hsa-miR-200c-3p;hsa-miR-23a-3p;hsa-miR-27b-5p;hsa-miR-769-5p;hsa-miR-940 10 ETS1 Sponge network -2.778 8.0E-5 0.008 0.97952 0.268
43

DGCR5

hsa-let-7g-5p;hsa-miR-107;hsa-miR-126-5p;hsa-miR-1266-5p;hsa-miR-140-3p;hsa-miR-148a-5p;hsa-miR-188-5p;hsa-miR-200a-5p;hsa-miR-200b-3p;hsa-miR-200b-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30d-3p;hsa-miR-30d-5p 14 ABL2 Sponge network 1.383 0.01835 0.257 0.18922 0.26
44

EMX2OS

hsa-let-7g-3p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-20a-5p;hsa-miR-335-3p;hsa-miR-33b-5p 10 PDGFRA Sponge network -1.088 0.10042 -1.161 0.00469 0.259
45

PCA3

hsa-miR-130b-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-335-5p;hsa-miR-424-5p;hsa-miR-590-3p;hsa-miR-590-5p 10 SOS2 Sponge network -2.778 8.0E-5 -0.553 0.00084 0.258
46

PCA3

hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-200c-3p;hsa-miR-330-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p 11 PRKACB Sponge network -2.778 8.0E-5 -2.003 0 0.257

Quest ID: 7dc1bcb910b2b9d235a72e18351e725f